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SUMMARY 
 
A six-step synthesis of salbutamol from methyl salicylate with an overall yield of 17% 
has been completed, although the yield was not optimised.  In the process, Zn(BH4)2 was 
found to selectively reduce a ketone carbonyl group in the presence of an ester unit.  In 
contrast, borane was found to reduce both the ketone and ester carbonyl groups. 
 
Reduction of phenacyl bromide with borane in the presence of chiral catalysts based on 
(R)-alaninol and (R,S)-ephidrine resulted a measure of enantioselectivity in the product.  
However, the configuration of the alcohol obtained in the case of (R)-alaninol was 
contrary to expectations based both on experimental trends observed elsewhere as well as 
our own theoretical predictions. 
 
The asymmetric reduc tion of methyl 5-bromoacetyl-2-benzyloxybenzoate was 
accomplished with both borane and Zn(BH4)2 in the presence of a range of chiral 
catalysts.  Optically active products were obtained in all cases, although the optical 
rotations were significantly smaller in the case of Zn(BH4)2.  Unfortunately, we were not 
successful in determining the enantiomeric excesses of these reactions.  The use of a 
NMR lanthanide shift reagent resulted in a complex spectrum that was impossible to 
interpret unambiguously.  This presumably arises from the presence of several Lewis base 
sites in the product at which complexation with the shift reagent can take place.  It was 
also not possible to determine the optical rotation of salbutamol itself owing to the 
relatively small amount of material obtained. 
 
A conformational analysis of salbutamol, where NMR data was correlated with molecular 
modelling results, was successfully carried out and revealed a strong preference for that 
conformer family characterised by O–C–C–N and Ar–C–C–N torsion angles of ca. 60º 
and 180º, respectively.  Interestingly, these conformers are found to be stabilised by 
OH…N rather than NH…O hydrogen bonding.  This study has also confirmed the 
effectiveness of the MMFF94 force field for conformational analysis studies in 
compounds of this kind. 
 
 iii 
Lastly, a relatively simple method for modelling the BH3/oxazaborolidine reduction of 
ketones at the PM3 semiempirical MO level of approximation was devised.  This 
approach has provided insights into the mechanism of the reaction and has furthermore 
enabled us to predict the enantioselectivities likely to result from various catalysts and 
ketones.  In comparing our theoretical and experimental findings, an anomalous result 
was observed in the case of (R)-alaninol; this will have to be investigated further, 
particularly at the experimental level.  However, we believe that our approach provides a 
sound basis for aiding the design and screening of new, potentially better catalysts. 
 
Key words: asymmetric reduction, salbutamol, molecular modelling. 
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1. INTRODUCTION 
 
The preparation of chiral compounds has become one the most important and challenging 
areas of organic synthesis, not least in pharmaceutical applications. 
 
Many physiological phenomena arise from molecular interactions in which a chiral host 
molecule is required to differentiate between two enantiomeric guest molecules.  The two 
enantiomers may evoke very different responses, e.g., one may smell quite differently to 
the other.  Differences in the pharmacological responses of a pair of enantiomers can be 
even more dramatic.  At best one enantiomer may be effective and the other completely 
ineffective and harmless.  At worst, the other enantiomer may have an undesirable or 
even harmful effect.  A classic example of this was the drug thalidomide (1) that was used 
some decades ago for the treatment of morning sickness in pregnant women. 
(1) 
The formulation was administered as a racemic mixture in which the (R)- isomer had the 
intended sedative effect. However, the (S)- isomer was discovered to be teratogenic and 
resulted in severe birth defects. 
 
Hence, the development of practical methods for the production of chiral compounds as 
the single desired stereoisomers is of great value in terms of both public safety and 
economic factors. Clearly, the synthesis of a chiral drug in its racemic form is not 
efficient if only one stereoisomeric form is active, since 50% of the final product will be 
useless and may require further treatment in the form of separation procedures, followed 
by possible recycling or safe disposal. It is notable that in 1992 the FDA in the USA 
introduced a guideline encouraging the commercialisation of single-enantiomer clinical 
drugs.1a   
 
In 2000 the worldwide market for single-enantiomer chiral fine chemicals was $6.63 
billion and projected to grow to $16.0 billion by 2007.1b 
N
O
O
N
HO
O
Thalidomide
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Asymmetric synthesis describes that area of organic chemistry in which the preparation of 
a specific stereoisomer is targeted and which does not rely on the elimination of one of a 
pair of steroisomers or on the isolation of one stereoisomer from a mixture of several. 
 
Generally, asymmetric synthesis can be accomplished through the use of: (i) chiral 
auxiliaries, (ii) chiral reagents and (iii) chiral ligands and catalysts.  A brief review of 
these techniques will be provided, but since one of the objectives of this project has 
involved the asymmetric reduction of ketones, discussion in this respect will be prefaced 
with a broad summary of reagents that are commonly used for the reduction of carbonyl 
compounds. 
 
1.1 Reagents for the Reduction of Carbonyl Compounds  
A wide variety of reagents have been developed for the reduction of carbonyl compounds, 
usually leading to the formation of alcohols.2, 3  Selected examples of common reagents 
which have also been applied to stereoselective reductions are broadly summarised 
below. 
 
1.1.1 Catalytic Hydrogenation 
Catalytic hydrogenation involves the addition of hydrogen gas (H2) to an organic 
molecule in the presence of a catalyst, which is usually a transition metal.  There are two 
major types of catalysis: heterogeneous  catalysis (where the catalyst is insoluble in the 
reaction medium) and homogeneous  catalysis (where the catalyst is soluble in the 
reaction medium).  Heterogeneous catalysis can be carried out in two ways: supported 
(both slurry and fixed gel processes) and unsupported (solution reactions).  
 
The most common heterogeneous catalysts used for the reduction of aldehydes and 
ketones include palladium supported on charcoal, Adam’s catalyst (PtO2) and Raney 
nickel.  However, the chemo- and stereo-selectivity associated with catalytic 
hydrogenation of carbonyl compounds are frequently unpredictable. 
 
Typical homogeneous catalysts include Wilkinson’s catalyst, (Ph3P)3RhCl, and the 
iridium complex, [Ir(COD)(Py)PCy3]+PF6-. 
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1.1.2 Lithium Aluminium Hydride (LiAlH4) 
Lithium aluminium hydride rapidly reduces most carbonyl compounds, including 
aldehydes, ketones, carboxylic acids, esters, anhydrides, acid chlorides, lactones, amides, 
carbamates, imides and lactams. 
 
The mechanism for the LiAlH4 reduction of simple carbonyl compounds is thought to 
involve the following steps:4 
Scheme 1 
 
According to this mechanism LiAlH4 should reduce four equivalents of the ketone.  Note 
that the aluminium hydride becomes increasingly coordinated with alkoxy substituents as 
the reduction proceeds, and the reactivity of each new hydride species decreases with 
increasing substitution. 
 
Aldehydes are reduced faster than ketones, because there is less steric hindrance in the 
transfer of hydride to the carbonyl carbon.  It has been observed that the rates of LiAlH4 
reductions are strongly influenced by steric effects, with the reduction of highly hindered 
ketones being known to take several days. 
 
R2CO
H3O
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R2CO
CH
R
R
O
H3Al
-
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H3Al
H
R
R CH
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O- Li+
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(R C
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O)3AlH
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(R C
R
O)2AlH2
- Li+
H
4  H C R
R
OH
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LiAlH4 has been found to reduce carbonyl compounds diastereoselectively, with the 
hydride in general being delivered from the least sterically hindered face of the molecule, 
as illustrated in the case of the ketone (2) which affords the alcohol (3) 
stereoselectively5(Scheme 2). 
Scheme 2 
Note that it is possible for hydride delivery to take place from the more hindered face in 
cases where special chelation or coordination effects favour binding from that side. 
 
Reduction of a,b-unsaturated carbonyl compounds may lead to conjugate reduction.  
This is particularly common for conjugated ketones where the b  carbon is relatively 
unhindered. 
 
Reduction of a carboxylic acid with one equivalent of LiAlH4 requires the consumption 
of three of the four hydrides in LiAlH4, leading to an alcohol as the product.  Acid 
chlorides, anhydrides and esters are also rapidly reduced.  In the case of conjugated 
esters, 1,4-reduction is sometimes observed.  Amides react differently, leading to amines 
as the final products. 
 
1.1.3 Alkoxyaluminates 
LiAlH4 is a powerful reducing agent which usually reduces a carbonyl group to its lowest 
oxidation state (e.g., -CO2Et ® -CHO ® -CH2OH) with little control on stopping the 
reduction at an intermediate stage.  However, greater chemoselectivity is frequently 
required in synthetic sequences where multifunctional compounds may be involved.   
 
It is found that the ‘reducing power’ of LiAlH4 can be moderated by replacing some of 
the hydrogen atoms with alkoxy groups and as a result, small differences in its rates of 
reduction for various functional groups can be exploited.  In this way it is possible to 
selectively reduce one functional group in the presence of another.  Examples of such 
O
O
O
Me
H
OTHP
O
O
Me
H
OTHP
OH
1) LiAlH4
2) H+
(2) (3)
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alkoxyaluminates include LiAlH(OMe)3, LiAlH(OEt)3 and LiAlH(OBut)3.  These reagents 
will selectively reduce aldehydes, ketones, esters and acid chlorides in the presence of 
epoxides, nitriles and amides, and have been found to reduce lactones to lactols. 
 
1.1.4 Bis-methoxyethoxyaluminium Hydride 
A significant advantage of sodium bis-methoxyethoxyaluminium hydride (Red-Alâ, 
Vitrideâ) (4) over LiAlH4 is its greater stability and solubility in aromatic hydrocarbon 
and ether solvents; it can thus be used conveniently where the inverse addition of 
hydrides is required. 
 
The reactivity of Red-Al is very similar to that of LiAlH4, reducing aldehydes, ketones 
and acid chlorides to alcohols.  Reduction of conjugated carbonyls gives mainly allylic 
alcohols; interestingly, the reduction selectivity can be changed from 1,2 to 1,4 through 
the addition of CuBr. 
 
1.1.5 Borohydrides 
1.1.5.1 Sodium Borohydride 
Sodium borohydride (NaBH4) is a very selective reagent, reducing aldehydes, ketones 
and acid chlorides in the presence of a range of other reducible functional groups such as 
esters.  Its lower reactivity compared with LiAlH4 also permits its use in solvents such as 
alcohols and water. 
 
1.1.5.2 Zinc Borohydride 
Changing the metal counterion of hydride reducing agents can significantly affect their 
reducing effect. For example, LiBH4 (prepared simply by reacting NaBH4 with LiBr) is a 
significantly more powerful reducing agent than NaBH4. It reduces aldehydes, ketones, 
acid chlorides, esters, lactones and epoxides, but not carboxylic acids.  Its main 
application is in the selective reduction of esters, when the ester is the most reducible 
group in the molecule. 
Al
O
O
OMe
OMe
H
H
Na
(4)         
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Zinc borohydride [Zn(BH4)2] (5) is easily prepared by heating NaBH4 and freshly fused 
ZnCl2 in dry THF under reflux for 3 days. The mixture is then allowed to cool and settle 
whereupon the colourless solution of Zn(BH4)2 is filtered and kept for later use. It is 
stable for up to 6 months. The apparatus involved should be dried and flushed with 
nitrogen before use. 
H
H
B
H
H
Zn
H
H
B
H
H
 
(5) 
It has been reported to effect very efficient chemo-, regio- and stereo-selective6 
reductions in several complex substrates where sodium borohydride failed to produce 
satisfactory results.  It is a mild reducing agent and can be used in a range of non-
hydroxylic solvents. Moreover, its high coordinating ability makes hydride transfer highly 
selective in substrates that contain coordination sites. Thus Zn(BH4)2 holds several 
distinct advantages over LiAlH4 and NaBH4. In spite of this, it has been used less as a 
regular reducing agent in the laboratory for the reduction of organic compounds, possibly 
because of its unavailability as a commercial product. 
 
Some examples illustrating the chemoselectivity of Zn(BH4)2 reductions are given below: 
 
(i) Reduction of aldehydes in the presence of ketones 
The selective reduction of aldehydes to alcohols in the presence of ketones and other 
reducible groups is a key reaction in organic synthesis. Generally, reducing reagents can 
be modified to chemoselectively reduce an aldehyde in the presence of a ketone by 
replacement of some hydride ions in the reagent with sterically bulky substituents or 
electron withdrawing groups in order to discriminate between the structural or electronic 
environments of the two types of carbonyl groups. It has been found that Zn(BH4)2 in 
THF provides excellent selectivity toward the reduction of aldehydes over ketones and 
other reducible groups. Some illustrative examples are given in Table1. 
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Table 1. Reduction of aldehydes vs. ketones to the corresponding alcohol with 
Zn(BH4)2 in THF 
Aldehyde Time (min) 
Reduction 
(%) Ketone 
Time 
(min) 
Reductio
n (%) 
PhCHO 30 100 PHCOMe 30 0 
Ph-CH=CH-CHO 30 100 Ph-CH=CH-COMe 30 15 
Me2CHCHO 5 100 Me2CHCOMe 5 15 
 
(ii) Reduction of saturated ketones in the presence of conjugated enones 
Selective reduction of saturated ketones in the presence of conjugated enones is often 
required in a multistep synthetic strategies. Various modified hydride reagents derived 
from lithium aluminum hydride and sodium borohydride have been reported to be useful 
for such reductions.7  Zn(BH4)2 in DME without any modification has been shown to be 
very efficient this respect.8 
 
Table 2. Reduction of saturated ketones vs. conjugated ketones with Zn(BH4)2 in DME 
Carbonyl 
Compound Temp (
oC) Time (min) Reduction (%) 
 
O
Me  
 
 
-15 
 
 
30 
 
 
100 
 
 
 
O
Me 
 
 
-15 
 
 
30 
 
 
0 
 
O
 
 
 
-78 
 
 
5 
 
 
100 
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Carbonyl 
Compound Temp (
oC) Time (min) Reduction (%) 
 
O
 
 
 
-78 
 
 
5 
 
 
14 
 
O
Me 
 
 
-15 
 
 
30 
 
 
100 
 
O
Me 
 
 
-15 
 
 
30 
 
 
0 
 
As shown in Table 2, the saturated ketones underwent clean and complete reduction, 
whereas under identical reaction conditions the corresponding conjugated enones 
remained unaffected. Thus the fact that it can be used in aprotic solvents, its compatibility 
with a variety of otherwise reducible groups, the absence of side products, and coupled 
with its superior and controllable selectivity make Zn(BH4)2 an attractive and useful 
reagent for the facile reduction of ketone functionalities in compounds that would be 
unable to tolerate harsher reagents. 
 
(iii) Reduction of aliphatic esters in the presence of aromatic esters 
The selective reduction of only one of two different carboxylic ester groups to alcohol 
through a simple and mild procedure is a challenging problem in the field of organic 
synthesis. While a large number of reagents are known to reduce esters efficiently, very 
few are able to do so selectively.9  
 
However, it has been observed that Zn(BH4)2 in DME under ultrasonic activation offers 
excellent selectivity toward reduction of aliphatic carboxylic esters in the presence of 
their aromatic counterparts.10  The results obtained with a variety of aliphatic and 
aromatic carboxylic esters are illustrated in Table 3.  With this procedure, acetates are 
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selectively deblocked in the presence of benzoates.  However, one drawback of this 
procedure is that when the reduction of conjugated olefin esters is carried out, the double 
bond may also undergo some reduction. Since carboxylic esters remain unaffected by 
zinc borohydride without sonification, the application of ultrasound extends the reductive 
properties of zinc borohydride. 
 
Table 3. Reduction of carboxylic esters to the corresponding alcohols with Zn(BH4)2 in 
DME under sonication 
Carboxylic Ester Time (h) Reduction (%) 
CO2Me
 
24 100 
CO2Me
 
24 0 
 
CH2CO2Me
 
18 100 
CO2Me
MeO  
24 0 
CH2CO2Me
 
24 100 
 
CH2CO2Ph
 
 
24 5 
 24 
100 (acetate) 
0 (benzoate) 
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Carboxylic Ester Time (h) Reduction (%) 
CH2CO2Me
PhCO2  
 
(iv) Reduction of carboxylic acids 
Although LiAlH4 and diborane (B2H6) reduce carboxylic acids, they have limited use for 
sensitive molecules due to the ir lack of selectivity. Carboxylic acids that are inert towards 
borohydrides under ambient conditions are, however, reduced to alcohols in the presence 
of additives.11 
 
Zn(BH4)2 can be used to reduce carboxylic acids in DME in the presence of 
trifluoroacetic anhydride.12 Presumably, the carboxylic acid forms a mixed anhydride on 
initial reaction with trifluoroacetic anhydride and then undergoes facile reduction with 
Zn(BH4)2 to furnish the corresponding alcohol. 
 
Table 4. Reduction of carboxylic acids with Zn(BH4)2 
Carboxylic Acids  Time (h) Products Yields (%) 
C6H5CO2H 48 C6H5CH2OH 55 
p-Cl-C6H4CO2H 48 p-Cl-C6H4CH2OH 75 
Homophthalic acid 24 3,4-Dihydroisocoumarin 80 
 
 
Several structurally varied carboxylic acids have been shown to be reduced to alcohols 
under this procedure, as shown in Table 4. Straight chain aliphatic carboxylic acids 
undergo reduction faster than aromatic carboxylic acids. Thus, selective reduction of an 
aliphatic carboxylic acid in the presence of an aromatic acid has been achieved in the 
reduction of homophthalic acid, producing 3,4-dihydroisocoumarin. 
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(v) Reduction of 2-nitrocycloalkanones to 2-nitrocycloalkanols 
The reduction of 2-nitroalkanones to the corresponding nitroalcohols is complicated 
because of the peculiar reactivity of these compounds, in which cleavage of the C(1)-C(2) 
and carbon-nitrogen bonds by the action of nucleophiles occurs under mild conditions.13  
Thus ring cleavage and/or denitration are common during reduction of these compounds 
with many reducing agents. Reduction of 2-nitrocycloalkanones with a stoichiometric 
amount of NaBH4 has been reported to give the corresponding nitrocycloalkanols,14a 
whereas the use of excess reagent led to ring cleavage.14b  However, it has been shown 
that Zn(BH4)2 in DME cleanly reduces 2-nitrocycloalkanones to the corresponding 
nitrocycloalkanols without any ring cleavage or denitration.15 
 
Table 5. Reduction of 2-nitrocycloalkonones to 2-nitrocycloalkanols with Zn(BH4)2 in 
DME 
Substrate Time (min) Product Yield (%) 
 
O
NO2
 
 
 
5 
 
OH
NO2
 
 
 
73 
 
O
NO2
 
 
 
5 
 
OH
NO2
 
 
 
69 
 
O
NO2
 
 
 
5 
 
OH
NO2
 
 
 
88 
 
O
Me
NO2
 
 
 
5 
 
OH
Me
NO2
 
 
 
84 
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 As shown in Table 5, a variety of 2-nitrocyloalkanones have been reduced under this 
procedure to give the corresponding 2-nitrocycloalkanols as mixture of stereoisomers in 
high yields. The experimental procedure is very simple compared to that for NaBH4. 
Moreover, use of excess Zn(BH4)2 also produces similar good results without any ring 
cleavage. Thus, this reagent avoids the disadvantages of sodium borohydride with regard 
to the amount of reagent required.14 
 
A very useful application of Zn(BH4)2 is in the diastereoselective reduction of 
hydroxycarbonyl compounds. 
(6:7 formed in 10:1 ratio)
N(Pri)2
OH O
OPh O
N(Pri)2
OH OH
OPh O
(7)
N(Pri)2
OH OH
OPh O
(6)
+
Zn(BH4)2
 
The zinc coordinates with both the carbonyl and hydroxyl oxygen atoms, forming a cyclic 
complex.  Hydride from the BH4- ion is then delivered to the carbonyl carbon from the 
less sterically hindered face of the molecule, leading to a strong preference for alcohol 
(6). 
 
1.1.6 Alkoxy- and Alkyl-borohydrides 
Alkoxyborohydrides tend to be less reactive than NaBH4. NaBH(OPri)3, which is stable in 
THF, reduces only aldehydes and ketones and is unreactive towards almost all other 
functional groups.16 Acyloxyborohydrides are highly selective, e.g., KBH(OAc)3 has been 
found to reduce aldehydes in the presence of ketones.17 
 
The reducing power of boron is significantly increased when alkyl groups are added. 
Thus LiBHEt3 (Super HydrideÒ) which is easily prepared by reacting LiH and BEt3 in 
THF, is one of the most powerful hydride sources available.18  Its use in reducing 
aldehydes and ketones is largely confined to cases where no other reducible groups are 
present.  Super Hydride usually results in 1,2-reduction of conjugated carbonyl 
compounds as illustrated in (8) below, where high diastereoselectivity is also 
demonstrated.19 
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LiBHEt3
THF, -20o
O
O
O
O
O
(8)
O
O
O
O
HO
(9)  
    
Scheme 3 
Replacement of the ethyl groups in Super Hydride with bulkier alkyl groups greatly 
improves the diastereoselectivity of the reducing agent in its reduction of prochiral 
carbonyls.  Potassium tri-sec-butylborohydride, KBH(CH3CHCH2CH3)3, known as K-
SelectrideÔ, as well as the corresponding lithium derivative (L-SelectrideÔ), both reduce 
carbonyl compounds to alcohols in high yields, even at temperatures as low as –78°C.20  
Diastereoselectivities can be improved further through the inclusion of metal salts such as 
MgBr2 in the reaction mixtures.21 
 
Sodium cyanoborohydride (NaBH3CN) is a remarkably stable reagent, even in acid 
solutions (pH>3), and is unreactive, making it highly selective. Aldehydes and ketones 
are stable towards NaBH3CN under neutral conditions, but are rapidly reduced in acidic 
solutions.22 
 
1.1.7 Borane, Aluminium Hydride and Derivatives 
1.1.7.1 Borane 
Diborane (B2H6) is an excellent reducing agent for aldehydes, ketones, lactones, 
epoxides, acids, tertiary amides and nitriles.  Esters are reduced slowly which allows 
aldehydes and ketones to be reduced selectively in the presence of esters.  However, its 
most common application is for the selective reduction of carboxylic acids in the presence 
of a range of other reducible groups.23 
 
In comparison with the metal hydride reagents, borane is a good Lewis acid and 
coordinates with atoms with high electron density. 
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A number of derivatives of borane with different reduction selectivities have been 
developed.  For example, bis(1,2-dimethylpropyl)borane and 9-borabicyclo[4.4.1]nonane 
(i.e.,  9-BBN) reduce esters faster than borane does.  The greater steric bulk of such 
reagents also generally improves their selectivity in the reduction of prochiral ketones. 
 
1.1.7.2 Aluminium Hydride 
Aluminium hydride (AlH3) is analogous to BH3 in that it is also able to function as a 
Lewis acid, which can alter its reduction selectivity compared with AlH4-.  AlH3 reduces 
aldehydes, ketones, acid chlorides, epoxides, acids, tertiary amides and nitriles.  However, 
it is particularly useful for the selective 1,2-reduction of conjugated aldehydes, ketones 
and esters, as illustrated in the reaction of (10) where the allylic alcohol was obtained in 
94% yield.23 
 
SiMe3
CO2Me
(CH2)5CH3
(10)
SiMe3
CH2OH
(CH2)5CH3
(11)
AlH4
ether, 0oC
 
    
Scheme 4 
 
The selectivity can be ascribed to strong coordination between the carbonyl oxygen and 
AlH3.  1,2-Reduction then follows readily via a four-center transition state; clearly the 
six-center transition state required for 1,4-reduction is not easily attainable. 
 
Note that a disadvantage of AlH3 is the fact that its preparation through reacting LiAlH4 
with AlCl3, frequently leads to contamination with the mixed chloroaluminium hydrides 
ClAlH2 and Cl2AlH. 
 
1.1.7.3 Diisobutylaluminium Hydride (DIBAL) 
Diisobutylaluminium hydride {[(CH3)2CHCH2]2AlH, DIBAL} is a powerful reducing 
agent and is commonly used for the reduction of esters, lactones and nitriles.  It is also 
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successful for the reduction of aldehydes and ketones, frequently displaying high 
diastereoselectivity, e.g., (12).24 
+Ph
Ph
O
OMeH
(12)
Ph
Ph
OMeH
HO H
(13) (99%)
Ph
Ph
OMeH
H OH
(14) (1%)
Dibal
THF
-78oC
 
  
Scheme 5 
 
1.2 Asymmetric Reductions of Carbonyl Groups  
Generally, asymmetric synthesis can be accomplished through the use of: (i) chiral 
auxiliaries, (ii) chiral reagents and, (iii) chiral ligands and catalysts. 
 
1.2.1 Chiral Auxiliaries 
A chiral auxiliary is a chiral molecule, usually naturally-occurring, which is attached to a 
reactive molecule and provides facial selectivity (and hopefully orientation control as 
well) in a reaction.  After the reaction is complete, the auxiliary must be removed to 
regenerate the original functional group. 
 
There are two approaches: 
(i) the chiral auxiliary is attached to an achiral substrate 
(ii) the chiral auxiliary is attached to an achiral reagent and catalyst. 
 
The general sequence of events is illustrated in Scheme 6 where the chiral starting 
material is an achiral carboxylic acid, the chiral auxiliary is represented by A*, E is the 
reagent and C* is the new stereogenic centre. 
 
RCH2CO2H RCH2COA* RC*HCOA*
E
RC*HCO2H
E
remove
auxiliary
append
auxiliary
(i) Base
(ii) E+
 
Scheme 6 
 
The two features that characterise an ideal chiral auxiliary are: 
 Page 1.16 
(i) a functional group that permits the ready attachment and removal of the auxiliary 
before and after the stereocontrolled reaction, respectively and, 
(ii) a sterically demanding structure. 
 
In practice, it is the latter condition that provides the element of stereocontrol. 
 
1.2.2 Chiral Reagents 
Reduction of an unsymmetrical ketone R1COR2 with reagents such as sodium 
borohydride or lithium aluminium hydride yields a racemic mixture of the secondary 
alcohol R1R2CHOH. However, if an asymmetric reagent were to be used, it would be 
expected to react with an achiral substrate to give predominantly one chiral product. 
 
1.2.2.1 Modified Sodium Borohydride 
The asymmetric reduction of acetophenone with NaBH4 has been carried out in aqueous 
chiral micelles25,26 formed by chiral surfactants such as N-dodecyl-N, N-
dimethylephedrine bromide.  The enantiomeric excess obtained in such reactions is, 
however, not very high. 
 
A reagent for asymmetric reduction has been prepared by reacting sodium borohydride 
with monosaccharide derivatives containing free hydroxyl groups, e.g. (15).27  Similarly, 
another chiral borohydride (16) has been prepared as the potassium salt of a xylose 
derivative.28  
O
O
O
O
O
OH
(15) (16)
B
OH
O
O
O K
 
 
1.2.2.2 Modified Lithium Aluminium Hydride 
Chiral modifications of LiAlH4 have been prepared by reacting LiAlH4 with chiral natural 
products of known absolute stereochemistry such as (-)-camphor, prior to the introduction 
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of the prochiral ketone.29  However, usually only moderate asymmetric induction has 
been observed. 
 
A variety of other natural products have been attached to LiAlH4, such as (-)-quinine to 
give (17), and ephedrine to give (18). Reduction of acetophenone with (17) gave (R)-2-
phenylethanol in 48% ee, while the use of (18) resulted in 13% ee. 
 
Other examples of modified LiAlH4 are those obtained from its reaction with (-)-
(1R,2S,3S,5R)-anilinopinanediol, and (-)-(1R,2S,3S,5R)-10-N-methylanilinopinanediol 
(which were in turn prepared from (-)-ß-pinene); both complexes have been used to effect 
reductions in good yields, but with poor enantiomeric purities.30 A similar situation has 
been reported for the LiAlH4 complexes prepared from 1,2,5,6-di- isopropylidenemannitol 
and chiral alcohols such as (1R,2S,5R)-(-)-menthol or S-(+)-3-methyl-2-butanol.31  
 
The importance of Binal-H (19), prepared from 2,2'-dihydroxy-1,1'-binaphthyl, as an 
asymmetric reducing agent is well-known.32  
 
N
H OAlH3
N
MeO
H
H
(17)
O
AlH2
N
H Me
H
H
Me
Ph
H
(18)
8  
 
O
O
Al
H
OEt
Li
(19)
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The crowned 2,2'-dihydroxy-1-1'-binaphthyl derivative (20) has also been shown to 
impart asymmetric reducing capability to LiAlH4 for various prochiral ketones (Scheme 
7). 
Scheme 7 
 
The configuration of the six-membered, chelated transition state imposes the 
configuration of the alcohol. Similarly, chiral 2,2'-dihydroxy-4,4',5,5',6,6'-
hexamethoxybiphenyl, a Binal analogue, is another asymmetric reagent that can be used 
to effect reduction of a wide range of ketones.33 
O
O
Al
O
Et Li
H
C
CH
3
Ph
O
 
(21) 
 
The six-membered cyclic transition structure is biased to conformationally rigid cis,cis-
spiro [4.4]-nonane-1,6-diol. Phenyl alkyl ketones have been reduced using (22) and 
LiAlH4 to yield highly enantiospecific alcohols (Scheme 8). 
 
 
Ph
H
CH3
OH
LiAlH4/EtOH
Ph CH3
O
(20)
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O O
O O
O
O
O
O
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H
OH
O O
O O
O
O
OH
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PhCOMe
Li
O
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O
O
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O
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H
MeMe
OHPh
H(+)-(22)      +
LAH EtOHOH
H
H OH
O
O
AlHOEt
O
O
AlH2
(+)-(22)
 
Scheme 8 
 
1.2.2.3 Modified Borane 
Numerous chiral boranes have been developed fo r the asymmetric reduction of carbonyl 
compounds. A simple example is (R,R)-2,5-dimethylborolane (23, Masamune’s 
reagent).34 However, even earlier, the reaction of a-pinene and diborane had been shown 
to give (-)-(1R,2S,3R,5R)-diisopinocampheylborane (24) which was found to reduce 
carbonyl compounds to alcohols with high asymmetric induction.35 
H
Me
Me
Me
B
O
R
H
(26)
B
H
Me Me
(23)
B H
2
(24) (25)
B
H
 
Trialkylboranes have also been found to reduce carbonyl compounds, but by a different 
mechanism; the source of hydride is no longer B-H, but rather C-H.  To this end, chiral 
boranes such as Midland’s complex between a-pinene and 9-borabicyclo[4.4.1]nonane 
(25, B-Ipc or Alpine BoraneÒ) were developed and have been used for the asymmetric 
reduction of aldehydes and ketones, frequently with high enantioselectivity.36  The source 
of hydride is the tertiary b-H shown, and the enantioselectivity of the hydride transfer can 
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be ascribed to the fact that the sterically more favourable complex between the carbonyl 
species and the borane is the one shown in (26) where steric repulsion between the 
equatorial methyl group and the larger carbonyl substituent (R, in this case), is minimised.  
As a result, hydride transfer occurs selectively to the re face of the aldehyde.  
 
B-Ipc has been found to be less effective in the case of relatively unreactive ketones, but 
this has been remedied by increasing the Lewis acidity of the boron atom so that stronger 
coordination between the carbonyl oxygen and the boron atom results.  Examples of 
derivatives where this has been achieved include diisopinylcampheyl chloroborane 
(Ipc2BCl, 27),37 2-ethyl-diisopinylcampheyl chloroborane (Eap2BCl, 28), and 2-b-
chloroethyl-diisopinylcampheyl chloroborane (Cleap2BCl, 29). 
 
A borane reagent system that is recommended to yield good results in the reduction of 
unfunctionalized ketones comprises a mixture of 2,5-dimethylborolane (30) in the form of 
a lithium salt and the corresponding mesylate (32).  This mixture may be prepared by 
reacting the borohydride (30) with methanesulfonic acid (Scheme 9).   It is thought that 
the mesylate behaves as a catalytic Lewis acid, activating the carbonyl while 
simultaneously ensuring selectivity in the approach of the borane. 
BH2
- Li+
Me
Me
(30)
BH
Me
Me
(31)
BOMs
Me
Me
(32)
+MsOH
 
Scheme 9 
1.2.2.4 Enzymic Reducing Agents 
In nature asymmetric reductions are widespread and 100% ee’s are common.  Nature uses 
enzymes as chiral reducing agents.  Man has not hesitated to explore this possibility, but 
problems are often experienced with the use of enzymes because they have usually 
B Cl
2
(27)
B Cl
2
(28)
B Cl
Cl
2
(29)
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evolved to be highly substrate-specific and their general use may therefore be limited.  
However, this problem can be overcome through the use of multi-enzyme systems.  
 
Baker’s yeast (Saccharomyces cerevisiae) is particular good at reducing ketones, with the 
best enantioselectivities being obtained when the ketone carries a ß-ester group.   
 
CO2Et
O
CO2Et
OH
Baker's yeast
glucose  
Scheme 10 
The reactions can be tedious, but the use of immobilised yeast cells has shown greater 
stability of the yeast, higher product formation rates and easier product isolation.38,39  
 
Complexation of the substrate with organometallics such as ferrocene or Cr(CO)6, 
followed by baker’s yeast mediated reduction, has also produced good results in the case 
of ketones. 
 
Scheme 11 
 
1.2.3 Chiral Catalysts 
1.2.3.1 Hydrogenation 
Asymmetric induction during hydrogenation is possible provided a chiral catalyst is 
used.40   In the case of heterogeneous systems this may be achieved through the inclusion 
of a chiral compound which is capable of coordinating with the transition metal (e.g., (S)-
methionine with Pd/C, or tartaric acid with platinum). 
 
However, chiral homogeneous catalysts have proved to be significantly more effective. 
Typically, such catalysts are based on a modification of Wilkinson’s catalyst in which 
triphenylphosphine is replaced by a chiral tertiary phosphine, bis-, or tris-phosphine.  
C
CH3
HO H
C
CH3
O
Cr(CO)3
S. cerevisiae
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Noyori’s research group have exploited this concept, in the process developing an 
effective method for the asymmetric hydrogenation of ketones.41 
 
Their approach was based on the use of BINAP [2,2’-bis(diphenylphosphino)-1,1’-
binaphthyl] as the phosphine ligand for the construction of a range of chiral catalysts with 
the general structure shown below. 
 
 
 
 
 
 
 
 
 
 
(33) 
BINAP/diamine Ru(II) complexes of the type shown above have been found to catalyse 
rapid and highly enantioselective hydrogenation of a wide range of aromatic, 
heteroaromatic, and olefinic ketones in 2-propanol containing t-BuOK or KOH.41  In this 
respect, RuCl2(xylBINAP) (DAIPEN) is particularly effective.  For example, 
acetophenone and its derivatives are reduced quantitatively to 2-phenylethanol in 99% 
ee.42  A particularly valuable feature of this catalytic system is that, unlike normal 
catalytic hydrogenation where alkenes are generally more reactive than carbonyl groups, 
it is able to preferentially saturate a C=O linkage in the presence of a C=C bond.43  As a 
result, unsaturated ketones can be converted into olefinic alcohols. 
 
1.2.3.2 Transfer Hydrogenation 
Transfer hydrogenation encompasses reductions of the Meerwein-Ponndorf-Verley 
(MPV) type44 in which a ketone is reduced to alcohol upon treatment with Al(OPri)3 in i-
P
Ar2
Ar2
P
Ru
H2
N
N
H2
R2
R3
R1
R4
Cl
Cl
(S)-BINAP/(S)-diamine-Ru(II) catalyst
(S)-BINAP:  Ar = C6H5
(S)-TolBINAP:  Ar = 4-MeC6H4
(S)-XylBINAP:  Ar = 3,5-Me2C6H3
(S,S)-DPEN:  R1 = R4 = C6H5; R
2 = R3 = H
(S)-DAIPEN:  R1 = R2 = 4-MeOC6H4; R
3 = H; R4 = Me2CH
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PrOH as solvent; hydrogen is effectively transferred from the solvent, which in turn is 
converted to propanone.   
 
In recent years there have been a number of reports of MPV reductions being adapted so 
as to provide chiral induction.  For example, the use of a chiral samarium catalyst (34) in 
place of Al(OPri)3 has been shown to asymmetrically reduce acetophenone and 
derivatives in good yields and with excellent ee’s.45  
 
A similar effect has recently been achieved under extremely mild conditions through the 
use of 1 mol% of the chiral amino alcohols (35) and (36) along with only 0.25 mol% of 
[RuCl2(p-cymene)]2 in i-PrOH as solvent containing 2.5 mol% KOH.46 
 
1.2.3.3 Borohydride Reductions 
Good yields and high enantioselectivities have been achieved in ketone reductions using 
NaBH4/MeSiCl catalysed by a chiral ß-hydroxysulfoximine47 (Scheme 12). It has been 
postulated48 that BH3-THF complex, formed when the reduction occurs with excess 
Me3SiCl in THF, functions as the reducing agent (Scheme 13). 
 
Ph Me
O
Ph Me
OH
NaBH4/Me3SiCl
CPh2
OHNH
S
Ph
(10%)  
Scheme 12 
THFNaBH4    +    Me3SiCl BH3.THF     +     NaCl     +     Me3SiH 
Scheme 13 
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N
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I
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In a more recent development, asymmetric induction has been observed in reductions 
using NaBH4 in the presence of a chiral polymeric support.  Polymer-supported catalysts 
include chiral natural products such as quinine, ephedrine and cinchonine,49 chiral 
quaternary ammonium groups50 as well as chiral amino alcohols.51 Such supports may be 
synthesised via the Merrifield procedure52 or through modification of styrene or 4-
vinylpyridine-divinylbenzene copolymers (Scheme 14) or by polymerisation of a 
functional chiral monomer. In the case of the Merrifield synthesis, the enantioselectivity 
obtained when Et3N was used for coupling the appropriate amino alcohol was found to be 
much lower than that obtained when the cesium salt method was used.  This is due to the 
formation of a quaternary ammonium salt,51 which acts together with NaBH4 as an ion 
exchange resin. The modification of styrene-divinylbenzene copolymers gave good 
results, which were further improved by the introduction of a spacer between the amino 
and alcohol groups.  However, the best results were obtained with supports synthesized 
by polymerisation of a chiral functional monomer.  
 
Scheme 14 
 
 
 
 
 
P P C (CH2)n Cl
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O
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1.2.3.4 Corey-Bakshi-Shibata (CBS) Reduction 
Examples given earlier have illustrated the use of chiral borolanes (e.g., Masamune’s 
reagent) in asymmetrically reducing ketones.  However, it has been shown that a similar 
effect can be achieved with B2H6 or catecholborane mediated by a chiral catalyst such as 
an oxazaborolidine.53  This approach (known as the Corey-Bakshi-Shibata reduction54) 
has developed into one of the most versatile and successful asymmetric reducing systems 
known. 
 
The use of 1,3,2-oxazaborolidines, e.g., (37) in asymmetric reductions was first reported 
by Itsuno et al.55 and from that a wide range of new catalysts and improved methods have 
grown.56,57 The CBS reduction is usually superior to related systems, as demonstrated 
when the poor results obtained from the reduction of ketones with LiAlH4 when 
complexed with the amino alcohols ephedrine, (+)-Me2NCH2CH(CMe3)CH2OH and 
[HOCH2CH(CMe3)CH2]2NH, are compared with the oxazaborolidine derived from (+)-
MeNHCH2CH(CMe3)CH2OH and borane, which was found to yield a reduction product 
of much greater enantiomeric purity.58  Oxazaborolidines have been derived from chiral 
compounds such as camphor,59 a-pinene,60ephedrine61 and naturally occurring L-amino 
acids.62,63  Since D-amino acids are more expensive, the use of derivatives of artificial 
compounds such as indoline,64 aziridine65 and pyrrolidine,66,67 as well as certain chiral 
waste products68,69 which can be obtained in either configuration have come to the fore. 
The use of either borane-dimethylsulfide, catecholborane or borane-THF solution as 
reductant produces similar yields,56 and in most instances the catalyst is easily 
recoverable.  
 
The most widely accepted mechanism for the reduction of carbonyl compounds using 
1,3,2-oxazaborolidines is that proposed by Corey et al.,70 (Scheme 15) although certain 
inconsistencies with experimental evidence have been reported by another group.71 
 
The mechanism has been proposed to involve coordination of the nitrogen atom of the 
catalyst with BH3, with the result that BH3 is activated as a hydride source. A further 
effect is to increase the Lewis acidity of the ring boron atom, which facilitates 
coordination with the carbonyl oxygen atom of the acetophenone; this leads to the 
carbonyl group becoming activated for nucleophilic attack.  The consensus is that the 
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stereochemistry of the complex is controlled by steric effects with the ketone prefering to 
adopt an orientation where the larger substituent is directed away from the 
oxazaborolidine moiety.  Hydride transfer then follows through a six-membered transition 
state, ensuring that the alcohol is formed enantioselectively. The excellent catalytic 
properties of the oxaborolidine additive clearly lie in the fact that it brings two reactants 
(BH3 and the carbonyl compound) into close proximity in a sterically crowded 
environment, followed by a stereocontrolled hydride transfer. 
The presence of even small amounts of water in the solvents has been shown to give 
much lower enantioselectivities although the reason for this is not yet fully 
understood.56,71  In contrast, the addition of stoichiometric amounts of triethylamine72  or  
boron trfluoroetherate66 have been found to increase the enantioselectivities of certain 
oxazaborolidine catalysed reactions.  
 
A variant of the above involves the use of the chiral oxazaborolidine (38) in conjunction 
with a stoichiometric amount of BH3 which has been shown to enantioselectively reduce 
a wide range of ketones, including aryl ketones and dialkyl ketones; e.g., acetophenone 
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(PhCOCH3) is reduced to (R)-1-phenylethanol.  Enantioselectivity would be expected to 
be improved by the presence of the B-butyl substituent. 
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Scheme 16 
 
Narasimhan and his coworkers73 have recently demonstrated that the chiral catalysts (39) 
and (40) are highly effective for the asymmetric reduction of prochiral ketones with 
borane. 
OH
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N
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O
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Note that in contrast to conventional amino alcohol catalysts, the ortho hydroxy group in 
(39) is utilised in forming the oxazaborolidine (41), while (40), being a tridentate ligand, 
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can be used to form the bicyclic oxazaborolidine (42).  The latter was found to reduce 
acetophenone to (R)-2-phenylethanol in 95% yield and with 90% ee. 
 
A variety of phosphinamides74,75 and oxaphospholidine oxides76, 77 have been 
enantioselectively employed to modify borane reduction in reactions similar to those of 
oxazaborolidines. The activity of the catalysts reaches its maximum when the ‘R2NPO’ 
system is planar,74 since this permits electron delocalisation from the nitrogen atom to the 
P=O bond. Additional substituents capable of donating electrons to the phosphinamide 
system increase the effectiveness of the catalyst. The mechanism for the reaction is shown 
in (Scheme 17). 
 
BH3
N+ P
R'
R'
O BH3
-
R
R
N P
R
R R'
R'
O
N+ P
R'
R'
O-R
R
PhCOCH3
N+ P
O BH-R
R O C
Ph
Me
H
R'R'
N+ P
O BH-R
R OR'R' C
Ph
Me
H
O C
Ph
Me
H
H2B
 
 
Scheme 17 
 
1.2.4 Cyclodextrins 
Cyclodextrins are useful in asymmetric synthesis since they provide a chiral cavity into 
which the substrate or reagent can be complexed.  Although enantioselective reactions 
can occur in such an asymmetric environment, the enantioselectivities observed are 
frequently relatively low. This can be attributed to the prochiral center either assuming an 
incorrect orientation in the cavity, or experiencing greater mobility than might have been 
anticipated.78 Mobility can be reduced through the use of crystalline inclusion 
complexes,79or through the inclusion of a second inert molecule (the co-guest) into the 
cavity.78          
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2. RESULTS AND DISCUSSION 
 
This research group is currently interested in the synthesis of (R)-salbutamol (43), which 
is widely used as a bronchodilator for the symptomatic relief of asthma.1  A key step in its 
pharmacology is the selective binding of the R-enantiomer to the b-2-adrenoreceptor 
which results in the formation of cAMP, leading to bronchodilatation.  However, there 
have been reports that the S-enantiomer could have the opposite effect, resulting in 
bronchoconstriction,2 or at best, be ineffective.1   
 
(R)-Salbutamol has been isolated through the diasteriomeric resolution of a racemic 
mixture.3  More recently, however, strategies for its enantioselective synthesis have been 
devised. 
 
Effenberg has reported an asymmetric synthesis for salbutamol based on a chiral 
cyanohydrin (Scheme 18).4  However, difficulties were encountered in the final 
deprotection step involving hydrolytic cleavage of the acetal, which was found to lead to 
racemisation. 
 
Scheme 18 
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X
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Hong et al.5 have shown that salbutamol can be enantioselectively prepared through the 
asymmetric reduction of the appropriate a-imino ketone (Scheme 19). 
Scheme 19 
 
In broad terms our interest in this project has been directed towards the asymmetric 
reduction of a-functionalised ketones of the general structure (44) that are appropriately 
functionalised at the 3- and 4-positions for conversion into salbutamol. 
 
 
More specifically, the objectives of this project were to: 
(i) complete a full synthesis of salbutamol; 
(ii) determine the efficacy of zinc borohydride, Zn(BH4)2, as a reducing agent for the 
ketones (44) (and possibly in the presence of chiral catalysts); 
(iii) investigate the use of selected chiral catalysts for the asymmetric BH3 reduction of 
the ketones (44); 
(iv)  computationally model the enantioselective reduction of simple model ketones 
based on (44) with BH3 in the presence of some typical oxazaborolidine catalysts. 
 
 
N
B
O
Ph
Ph
Me
catalyst  =
BH3/Me2S
catalyst
OH
OH
NBut
O
OH
OH
NHBut
HO
Z
O
X
R
where X  =  Br or NHBut,
R  =  OH or OCH2Ph,
and Z  = CO2Me or CH2OH      
(44)
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2.1 Preparation of Reagents 
2.1.1 Zinc borohydride 
  ZnCl2   +   NaBH4   ®   Zn(BH4)2   +   NaCl 
Zinc borohydride was prepared by treating fused zinc chloride with sodium borohydride 
in THF.  The Zn(BH4)2 was not isolated, but instead used as a THF solution whose 
concentration is about 4.4 M.6  The reagent is stable in solution under a nitrogen 
atmosphere for up to six months. 
 
The driving force for the reaction presumably lies in hard-soft acid-base theory;7 zinc(II) 
and BH4- are classified as a borderline acid and soft base, respectively, while Na+ and Cl- 
are both hard. 
 
2.1.2 Borane 
3NaBH4   +   4BF3   ®   4BH3   +   3NaBF4 
Sodium borohydride was treated with boron trifluoride in anhydrous diglyme according 
to a standard procedure.8  The resultant gaseous BH3 was flushed from the system with 
nitrogen gas and trapped in THF.  The concentration of the BH3 solution prepared in this 
way is approximately 1M.  It can be stored at 0 °C for lengthy periods. 
 
2.1.3 (-)-(1R,2R,4S)-4-Isoprenyl-1-methyl-2-morpholin-4-yl-cyclohexanol (46) 
 
(+)-Limonene oxide (45) (used as a mixture of cis and trans) was reacted with 
morpholine and after the excess limonene oxide was distilled off under reduced pressure, 
the crude amino alcohol (46) was isolated as its oxalate salt.  Purification of the salt was 
followed by liberation of the free amino alcohol through basification and extraction into 
ether which was dried.  (-)-(1R,2R,4S)-4-Isoprenyl-1-methyl-2-morpholin-4-yl-cyclo-
hexanol was obtained upon removal of the solvent. 
O OH
N
O
O
N
H
+
(45) (46)
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2.2 Preparation of the Salbutamol Precursors  
The strategy used for the preparation of a prochiral ketone suitable for asymmetric 
reduction and subsequent conversion into salbutamol is outlined in Scheme 20. 
 
 
Scheme 20 
Methyl 2-hydroxy-benzoate (methyl salicylate, 47) was selected as the starting material in 
view of its ready availability and relatively low cost.  Friedel-Crafts acetylation of methyl 
salicylate with acetic anhydride in the presence of AlCl3 gave methyl 5-acetyl-2-hydroxy-
benzoate (48) in 80% yield.  The substitution pattern was confirmed by its 1H-NMR 
spectrum which contained singlets at 2.54 and 3.97 ppm (COCH3 and CO2CH3, 
respectively), a doublet at 6.99 ppm (Ar-3H), doublet of doublets at 8.04 ppm (Ar-4H), 
doublet at 8.43 ppm (Ar-6H) and singlet at 11.20 ppm (OH). 
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An option we followed was to protect the hydroxy group as a benzyl ether (in view of its 
ease of removal through hydrogenolysis at a later stage), through treating (48) with NaH 
followed by benzyl bromide, giving (51). An alternative synthesis used involved reacting 
(48) with anhydrous K2CO3, NaI and benzyl bromide in acetone. This reaction is believed 
to occur through halide exchange (i.e., the Finklelstein reaction)9 in which benzyl 
bromide is converted to the more reactive benzyl iodide, with the driving force being the 
fact that while NaI is soluble in acetone, NaBr is insoluble.  Benzyl iodide is not isolated, 
but is instead allowed to react with the phenoxide in situ. The benzyl ether (51) was 
obtained in 82% yield. Its 1H-NMR spectrum was similar to that of the phenol (48), 
except for the appearance of the methylene protons at 5.25 ppm as well as additional aryl 
protons in the region 7.31-7.82 ppm.  
 
The acetyl group required activation in order to ultimately allow introduction of the a-t-
butylamino group.  This was achieved through bromination of (51) with Br2 in HOAc, 
giving (52) in 62% yield.  The only significant change in the 1H-NMR spectrum of the 
product involved replacement of the acetyl methyl signal with a methylene signal at 4.42 
ppm. 
 
2.3 Ketone Reduction Reactions  
2.3.1 Zn(BH4)2 
Table 6  Zn(BH4)2 reduction of acetophenone and phenacyl bromide 
Ketone Solvent T/°C Product Yield/% 
PhCOCH3 DME -15 PhCHOHCH3 33 
PhCOCH3 DME 25 PhCHOHCH3 96 
PhCOCH3 Et2O 25 PhCHOHCH3 40 
PhCOCH2Br DME 25 PhCHOHCH2Br 83 
 
Firstly, the use of Zn(BH4)2 was tested on acetophenone and phenacyl bromide (2-bromo-
1-phenyl-ethanone).  The results are summarised in Table 6.  In both cases the required 
alcohol was obtained in good yield. 
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Next the ring substituted ketone derivative (52) was also treated with Zn(BH4)2 at 0°C 
and was found to undergo selective reduction of the ketone carbonyl while the ester group 
remained unaffected.  The alcohol (54) was obtained in 80% yield. 
 
2.3.2 Borane (BH3) 
In contrast to Zn(BH4)2, when the keto ester (52) was reduced with BH3 in THF at 30°C, 
both carbonyl groups were reduced, giving the diol (55). 
 
2.3.3 Asymmetric reductions 
2.3.3.1 Phenacyl bromide 
A survey of the literature10 indicates that when phenacyl bromide is reduced with BH3 in 
the presence of oxazaborolidine catalysts where the configuration at C(4) (i.e., the C-atom 
adjacent to N) is S, then (S)-2-bromo-1-phenylethanol is usually obtained.  
 
Outlined in Table 7 are the results obtained for the attempted asymmetric reduction of 
phenacyl bromide, which can serve as a model for the salbutamol precursor methyl 5-
bromoacetyl-2-benzyloxybenzoate (52).  Both (R)-alaninol and (R,S)-ephedrine produced 
the S-configuration of the alcohol.  In the case of alaninol, where the configuration at 
C(4) in the expected oxazaborolidine is R, the result is contrary to expectation. 
 
Table 7.  Catalysed BH3 reduction of PhCOCH2Br to PhCHOHCH2Br. 
Reductant Catalyst Yield/% [a]D/° ee/%* Absolute configuration 
BH3 (R)-alaninol 88 +2.3 6 S 
BH3 (R,S)-ephedrine 83 +16.1 38 S 
Zn(BH4)2 (R,S)-ephedrine 79 +8.3 20 S 
* Estimated from the specific rotation of -39° reported for (R)-2-bromo-1-phenylethanol 
(93% ee).11 
OCH2Ph
CO2Me
Br
HO
(54)
OCH2Ph
Br
HO
OH
(55) (56)
OCH2Ph
NHBut
HO
OH
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2.3.3.2 Methyl 5-bromoacetyl-2-benzyloxybenzoate (52). 
The asymmetric reduction of methyl 5-bromoacetyl-2-benzyloxybenzoate (52) with a 
range of reducing systems was attempted and the results are reported in Table 8.  
 
Table 8.  Catalysed BH3 and Zn(BH4)2 reductions of ketone (52). 
Reductant Catalyst Ketone Product Yield/% [a]D/° 
BH3 (R)-alaninol (52) (55) 93 +24.4 
BH3 (R,S)-ephedrine (52) (55) 88 +35.5 
BH3 (46) (52) (55) 84 -161.8 
BH3 mercapto-iso-borneol (52) (55) 93 -48.7 
Zn(BH4)2 (R)-alaninol (52) (54) 65 +1.8 
Zn(BH4)2 (R,S)-ephedrine (52) (54) 60 +6.8 
 
2.3.3.3 Determination of enantioselectivities of reduction reactions. 
We at first decided to determine the enantioselectivities of the asymmetric reductions of 
acetophenone and phenacyl bromide through reacting the resulting alcohols with (1S)-(+)-
10-camphorsulfonyl chloride, in anticipation of being able to resolve the NMR spectra of 
the resulting diastereoisomeric sulfonate esters (Scheme 21).   
 
However, the esters which were obtained from the reaction with racemic 2-phenylethanol 
could not be resolved from either their 300 MHz 1H or 75 MHz 13C NMR spectra.  Hence 
it was decided not to pursue this route further.  A further potential problem lay in the fact 
that in the salbutamol synthesis sequence two alcohol groups could be present [see, e.g., 
(55)].  Complex NMR spectra would be expected to result if esterification of both 
hydroxy groups were to occur. 
(S) (R,S) + (S,S)(R),(S)
OClO2S
OSO
O
O
CHPh
MePh CH OH
Me
+
 
Scheme 21 
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It was therefore decided to rely on optical rotations to determine enantioselectivities in 
the case of the acetophenone and phenacyl bromide reductions, since the specific 
rotations for both alcohols are known. 
 
In the case of the salbutamol precursor (55) an attempt was made to resolve the 
enantiomers through the use of an NMR chiral shift reagent, praseodymium 
tris(trifluoromethylhydroxymethylene)-(+)-camphorate.  However, this proved to be 
unsuccessful since a complex spectrum that was impossible to interpret, resulted.  This 
can be attributed to the fact that in the diol (55) several Lewis base sites are available for 
complexation. 
 
Although the products (54) and (55) which resulted from asymmetric reductions were 
found to be optically active, their enantiomeric excesses were not determined.  
Unfortunately a lack of time prevented this aspect of the study from being completed, but 
it is hoped that in future it could be reinvestigated. 
 
2.4 Amination Reactions  
Attempts to introduce the t-butylamino group in the ketones (49) and (52) proved to be 
unsuccessful.  Refluxing methyl 5-(a-bromoacetyl)-2-benzyloxybenzoate (52) in tert-
butylamine for seven days gave a complex mixture which was abandoned.  A similar 
result was obtained when the bromoketone (52) was treated with N-benzyl-N-tert-
butylamine. 
 
It is possible that the bromoketone undergoes competing reactions such as imine 
formation and even base-catalysed enolisation of the ketone rather than the desired 
substitution reaction.  It was therefore decided to introduce the amino group after 
reducing the bromoketone to bromoalcohol. 
 
2-Bromo-1-(4-benzyloxy-3-hydromethylphenyl)ethano l (55) was dissolved in tert-
butylamine and the solution refluxed for a week, giving 2-t-butylamino-1-(4-benzyloxy-
3-hydroxymethylphenyl)ethanol (56) in 71% yield. 
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2.5 Debenzylation Reactions  
The final stage of the synthesis involved debenzylation of the ether (56) through 
treatment with hydrogen over palladium on charcoal at a pressure of 800 bar.  Salbutamol 
(44) was obtained in 76% yield. 
 
We were thus successful in synthesising salbutamol from methyl salicylate in six steps 
with an overall yield of 17%. 
 
2.6 Conformational Analysis of Salbutamol 
The 1H-NMR chemical shifts and assignments for salbutamol (57) as recorded in d6-
acetone are summarised in Table 9.  The assignment of Ha, Hb and Hc are straightforward.  
He and He¢ are diastereotopic and hence display different chemical shifts; there is also a 
large mutual coupling of 11.3 Hz.  Hd couples more strongly to He¢ than to He.  This may 
be interpreted as evidence for a preferred conformation (or family of conformers) in 
which the Hd-C-C-He¢ torsion angle is significantly closer to 0° or 180° than is the case 
for Hd-C-C-He.14   
 
Shown in Fig. 1 is the structure of salbutamol where H-bonding between the amino and 
hydroxy groups is represented.  The three low energy rotamers associated with the amino 
alcohol side chain are shown.  The two gauche¶ rotamers (57g) and (57g’) are likely to be 
stabilised through intramolecular H-bonding.  The NMR data suggests that the average 
rotamer distribution resembles (57g) more than (57g’) or (57t). 
O
NH
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But
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OAr
He'
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N
(57t)
 
Fig. 1  Selected rotamers of salbutamol 
                                                 
¶ The gauche and trans rotamers shown are defined according to the relative orientations 
of the amino and hydroxy groups. 
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Table 9 1H-NMR data for Salbutamol. 
Proton Chemical shifts/ppm Splitting Coupling constants/Hz 
Ha 7.27 d Jab 2.0 
Hb 7.11 dd 
Jba 2.0 
Jbc 8.2 
Hc 6.77 d Jcb 8.2 
CH2OH 4.73 s  
Hd 4.50 dd 
Jde 3.7 
Jde¢ 9.1 
He 2.76 dd 
Jed 3.7 
Jee¢ 11.3 
He¢ 2.57 dd 
Je¢d 9.1 
Je¢e 11.3 
C(CH3)3 1.09 s  
The OH and NH signals were not distinguishable from a residual water signal 
at ca. 3.0 ppm present in the solvent, d6-acetone. 
 
Since salbutamol is a physiologically active compound that is required to interact with a 
receptor site in a highly specific way, it seemed appropriate to explore its conformational 
hyperspace at a theoretical level and to then attempt to correlate these results with the 
NMR data given above.  To this end, conformational searches were conducted at both the 
molecular mechanics (using the MMFF94 and SYBYL force fields) and semiempirical 
molecular orbital levels of approximation (AM1 and PM3 hamiltonians) as implemented 
in Spartan ’02 for Linux running on a PQS Quantum Station QS4-1800S machine.§ In 
addition, the geometries of the conformers obtained with the force field calculations were 
subjected to further refinement at both the AM1 and PM3 semiempirical levels.  
Furthermore, aqueous solvation energies, based on the SM5.4 model of Cramer and 
Truhlar13 were estimated for each conformer. 
 
The energies, along with selected structural parameters such as torsion angles and 
interatomic distances of the sets of conformers obtained in each case, have been tabulated 
elsewhere (see Appendix). 
                                                 
§ The results obtained should be seen in the context of observations made by Hehre and 
his coworkers12 who, on the basis of a statistical analysis of the conformational energy 
differences of a series of acyclic molecules computed by a range of methods, concluded 
that the SYBYL force field was unsatisfactory for this purpose, while the MMFF94 
model is significantly better than any of the semiempirical methods and is, in fact, of 
similar accuracy as the best HF and correlated models. 
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It can be assumed that the sets of conformers obtained in this way will take up Boltzmann 
distributions based on their relative energy differences.  Hence, the population probability 
Pi of a conformer i of energy Ei at a temperature T can be calculated from: 
 
where k is the Boltzmann constant.  Where there are n conformers involved, the 
population probability for each conformer can be expressed as a mole fraction by 
applying the equation: 
å -
-
= n
i
kTE
kTE
i
i
i
e
e
P
/
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Illustrative data are shown in Table 10. 
 
Table 10 Illustrative data for the MMFF94 (gas phase) calculation of a torsion 
angle as a weighted average of the torsion angles of the component conformers. 
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1 0.00 7.68E-01 -53 2.16 3.10 -59 45.5118 -177 136.3614 
2 5.68 7.77E-02 -54 2.18 3.11 -60 4.6535 -178 13.8386 
3 5.73 7.63E-02 -53 2.16 3.11 -59 4.5221 -178 13.5403 
4 6.74 5.06E-02 -53 2.16 3.10 -59 2.9949 -177 8.9815 
5 10.82 9.78E-03 -54 2.18 3.12 -60 0.5854 -178 1.7412 
6 11.94 6.23E-03 -54 2.18 3.11 -60 0.3728 -178 1.1093 
7 14.97 1.83E-03 -53 2.15 3.10 -59 0.1083 -177 0.3247 
8 15.61 1.41E-03 48 3.13 2.33 44 0.0614 -73 0.1035 
9 15.66 1.39E-03 -53 2.17 3.11 -59 0.0824 -178 0.2461 
10 16.28 1.08E-03 -53 2.16 3.11 -59 0.0641 -178 0.1917 
¼
 
¼
 
¼
 ¼
 
¼
 
¼
 ¼
 
¼
 ¼
 
¼
 
95 41.12 4.81E-08 175 4.42 4.42 167 0.0000 57 0.0000 
96 41.58 3.98E-08 -92 4.22 4.20 -91 0.0000 154 0.0000 
Sum   1.00         59.4   177.2 
 
For each conformer the computed torsion angles of interest (i.e., Hd-C-C-He and 
Hd-C-C-He¢) are multiplied by the mole fraction value for that conformer.*  The 
                                                 
* Note that the absolute values of the torsion angles are used in these calculations since 
the magnitude of the coupling constant is independent of the sign of the angle. 
kTE
i
ieP /-=
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weighted average torsion angle is then obtained by summing over all the conformers.  In 
the above case the weighted averages obtained for the torsion angles Hd-C-C-He and 
Hd-C-C-He¢ are 59° and 177°, respectively. 
 
The energy profile (displayed as the mole fraction at 298K) for the MMFF94 gas phase 
conformers is shown in Fig. 2a.  Also plotted are the O-C-C-N, Hd-C-C-He and 
Hd-C-C-He¢ torsion angles for each conformer.  The first thirteen conformers, which 
account for over 99% of the mole fraction total at 298K, are all of the conformer family 
type (57g),* with the exception of conformer 8, which is of the type (57g’).  Conformers 
14 to 44 are a mix of all three types (57g), (57g’), and (57t).  Conformers 45 to 64 are a 
mix of (57g) and (57g’).  The remaining conformers are predominantly (57t) and (57g), 
with a sprinkling of (57g’).  The conformer family type (57g) accounts for 45% of the total 
distribution, (57g’) 29%, and (57t) 26%. 
 
Fig. 2b displays the same data, except that it zooms in on the first four conformers that 
collectively account for 95% of the mole fraction total at 298K; furthermore the torsion 
angles for Hd-C-C-He and Hd-C-C-He¢ are expressed as absolute values.  The four 
contributing conformers clearly all have similar geometries with respect to the O-C-C-N 
                                                 
* Interestingly, these rotamers are stabilised mainly through OH…N rather than NH…O H-bonding. 
Fig. 2a  (R )-Salbutamol : Conformer Profile (MMFF94 - gas.)
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torsion with angles of 53°, and Hd-C-C-He and Hd-C-C-He¢ with torsion angles of 59° 
and 178°, respectively. 
Fig. 2b  (R )-Salbutamol : Conformer Profile (MMFF94 - gas.)
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The conformer distribution shows some changes when aqueous solvation effects are 
included (Fig. 2c).  The first two conformers in Fig. 2c are the same as in Fig. 2b, i.e., of 
the type (57g).  However, the energies of conformers 3 and 4 are raised to 19th and 20th in 
rank and are excluded in Fig. 2c.  Conformer 3 shown in Fig. 2c (which was ranked 19th 
in the gas phase) is of type (57t), but its mole fraction contribution is only 0.09%. 
Fig. 2c  (R )-Salbutamol : Conformer Profile (MMFF94 - aq.)
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Figs. 3a-3c display further information about the conformer distributions obtained.  It is 
clear that for the MMFF94 calculations that the frequency ranking for the conformers is 
(57g) > (57g’) > (57t) (Fig. 3a) and when the Boltzmann probablility weightings are 
included, conformer (57g) is overwhelmingly dominant for both the gas phase and 
aqueous environments (Figs. 3b and 3c). 
 
Fig. 3a Conformer Distributions (gaseous)
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Fig. 3b Conformer Distributions (gaseous)
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Fig. 3c Conformer Distributions (aqueous)
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Application of the SYBYL force field to the conformer search resulted in a completely 
different distribution to that obtained with MMFF94.  The frequency ranking for the 
conformers is (57t) > (57g) > (57g’) (Fig. 3a).  The Boltzmann weighted rankings are (57t) 
~ (57g) >> (57g’) in the gas phase and (57t) >> (57g) ~ (57g’) in the aqueous phase (Figs. 
3b and 3c, respectively).  There is also a more gentle gradation from the lowest to highest 
energy conformers, although the change is more rapid for the aqueous energies.  
 
Figs. 3a-3c also provide information about the conformer distributions obtained from an 
AM1 semiempirical MO conformer search.  We can see that the frequency ranking for the 
conformers is (57g) >> (57g’) > (57t) (Fig. 3a), and when the Boltzmann probablility 
weightings are included, conformer (57g) is once again dominant for both the gas phase 
and aqueous environments (Figs. 3b and 3c). 
 
In the case of the PM3 semiempirical MO conformer search, Fig. 3a reveals a conformer 
frequency ranking of (57g) > (57t) > (57g’).  The Boltzmann weighted distribution for the 
gas phase is similar to that obtained for AM1 (Fig. 3b), while in the aqueous phase the 
order is (57g) > (57g’) >> (57t) (Fig. 3c). 
 
The geometries of the sets of conformers obtained from the MMFF94 and SYBYL 
searches were also refined further at the AM1 and PM3 levels.  The results are also 
shown in Figs. 3a-3c.  The general trends are similar to those observed before, except in 
the case of the aqueous PM3 optimised structures where the weighted distributions are 
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(57g) > (57t) >> (57g’) for the MMFF94 structures, and (57g’) > (57g) >> (57t) for the 
SYBYL conformers.  
 
In each case the weighted average torsion angles computed for Hd-C-C-He and 
Hd-C-C-He¢ can be translated into coupling constants through application of the Karplus 
relationship14 which takes the form 
 
J(Hz)  =  A + Bcosq + Ccos2q 
 
where q  is the torsion angle (in radians) and A, B and C are empirical constants (the 
values A = 3, B = -1.1, and C = 5 were used in the present case).  The computed coupling 
constants, as well as the experimental values are shown in Tables 11 and 12. 
 
Both the coupling constants Jde and Jde', computed according to the MMFF94 force field 
for the torsion angles Hd-C-C-He and Hd-C-C-He¢, respectively, in the gas phase are in 
excellent agreement with the experimentally observed values (Table 11).  This result is 
consistent with the dominating effect of the conformer family (57g).  The SYBYL 
calculation is found to overestimate Jde somewhat and grossly underestimate Jde', since 
this method strongly diminishes the contribution of conformer (57g) compared with (57g¢) 
and (57t).  The AM1 and PM3 semiempirical MO methods underestimate both coupling 
constants slightly.  
 
Table 11 Computed (gas phase) and observed (d6-acetone) coupling 
constants for salbutamol. 
 Hd-C-C-He Hd-C-C-He' 
Method Torsion angle¶/° Jde/Hz Torsion angle¶/° Jde'/Hz 
MMFF94 59 3.7 177 9.1 
SYBYL 117 4.6 65 3.5 
AM1 72 3.1 169 8.9 
PM3 75 3.1 162 8.6 
AM1/MMFF94 69 3.3 157 8.3 
AM1/SYBYL 76 3.0 164 8.7 
PM3/MMFF94 69 3.2 168 8.9 
PM3/SYBYL 85 2.9 154 8.1 
Observed§ (59) 3.7 (177) 9.1 
¶ The absolute values of the computed torsion angles are given. § The torsion angles were 
computed from the coupling constants. 
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A similar trend is found for the aqueous calculations (Table 12), with the anomalous 
effect observed with SYBYL being even more pronounced.  The magnitudes of Jde and 
Jde' are found to be switched in the PM3/SYBYL calculations also.  These effects are 
consistent with the computed conformer distributions (Fig. 3c). 
 
Table 12 Computed (aqueous phase) and observed (d6-acetone) coupling 
constants for salbutamol. 
 Hd-C-C-He Hd-C-C-He' 
Method Torsion angle¶/° Jde/Hz Torsion angle¶/° Jde'/Hz 
MMFF94 60 3.7 177 9.1 
SYBYL 156 8.2 67 3.3 
AM1 65 3.4 176 9.1 
PM3 55 4.0 151 7.8 
AM1/MMFF94 64 3.5 170 8.9 
AM1/SYBYL 75 3.1 166 8.8 
PM3/MMFF94 109 3.9 128 5.6 
PM3/SYBYL 51 4.3 109 3.9 
Observed§ (59) 3.7 (177) 9.1 
¶ The absolute values of the computed torsion angles are given. § The torsion angles were 
computed from the coupling constants. 
 
In conclusion, we have shown that the computational approach described above (and 
particularly when the MMFF94 force field is applied) can be successfully used to analyse 
the conformational preferences of salbutamol.  This has been verified through the 
excellent correlation between theory and experiment, where the Karplus equation 
provided the relationship between the observed Hd-C-C-He and Hd-C-C-He¢ proton 
coupling constants and the computed conformer distribution. 
 
2.7 Modelling BH3/Oxazaborolidine Reductions of Ketones 
2.7.1 Background 
The Corey mechanism of oxazaborolidine catalyzed borane reduction of ketones has been 
modelled by Nevalainen15 at the ab initio quantum mechanical level of approximation.  
Some of his main findings are summarized below. 
 
He has shown15n that when borane (BH3) bonds with the nitrogen atom of an 
oxazaborolidine system, the Lewis acidity of the ring boron increases significantly, 
thereby facilitating coordination of a ketone to the ring boron.  Furthermore, polarization 
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of the B-H bonds in the coordinated BH3 group increases, making the hydrogens more 
negative.  If it is assumed that the reducing power of borane adducts correlates with the 
strength of polarization of the BH3 moiety of the adducts, and if the values of the BH3-
oxazaborolidine complex are compared with computed values for H2O-BH3,  then it is 
evident that a BH3-oxazaborolidine complex is a stronger reducing agent than H2O-BH3.  
This implies that the potential reduction of a ketone by H3B-THF present in the reaction 
mixture should not seriously compete with reduction by the BH3-oxazaborolidine 
complex present in only catalytic amounts.¶  In support of this, computations show that 
the formation of BH3 adducts of ketones in the reaction of a ketone with H3B-THF should 
not seriously compete with BH3-oxazaborolidine adduct formation, since the latter 
process is more exothermic. 
 
Nevalainen has furthermore established that the formation of ketone-BH3-oxazaborolidine 
complexes is energetically feasible.  There are indications that there may be a small 
barrier for the formation of these complexes (low enough so that complex formation is 
likely to be reversible), while a second barrier is likely to apply for the hydride transfer.   
 
We ourselves have computed the optimum conformation for the complex between 
formaldehyde and the BH3-oxazaborolidine moiety, as well as the transition state 
structure associated with hydride transfer (Fig. 4) at the ab initio HF/6-31G* MO level of 
approximation.  In the initial complex the N-B-O=C torsion angle was found to be about 
75°, changing to about 66° in the transition state structure.  The most negatively charged 
hydrogen of the BH3 group is positioned about 2.49Å above the carbonyl carbon in the 
complex, closing in to about 1.82Å in the transition state.  Nevalainen has shown that the 
optimum conformation for hydride transfer is also the global energy minimum for the 
coordination of the ketone to the catalyst.15n 
 
                                                 
¶  However, it could be argued that since reaction of the ketone with reducing agent is a 
bimolecular process, a higher concentration of H3B-THF compared with BH3-oxazaborolidine 
complex could favour achiral reduction. 
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Fig. 4  (a) BH3/oxazaborolidine/HCHO complex; (b) transition state structure for 
H-transfer as computed at the HF/6-31G* ab initio MO level. 
Fig. 5  Complexation of acetaldehyde with H2B/NH2/BH3- 
 
Nevalainen has also shown15p that when acetaldehyde is complexed with a simple model 
of the BH3-oxazaborolidine adduct system, namely, H2B-NH2+-BH3- (Fig. 5), formation 
of the anti adduct is energetically more advantageous by 3.6 kcal mol-1 compared with the 
syn adduct.  This corresponds to an anti:syn ratio of 461:1 and an enantiomeric excess of 
99.8%. 
 
Ab initio calculations also show15o that coordination of an ethereal solvent to the Lewis 
acidic boron of the BH3-oxazaborolidine complex leads to stabilization of the latter which 
is energetically about 4-5 times more advantageous than coordination of a ketone.  As a 
result, the solvent is likely to inhibit coordination of the ketone. 
 
Shown in Scheme 21 are some potential reactive intermediates that could be implicated in 
the hydride transfer process for the ketone-borane complex of an oxazaborolidine 
anti complex syn complex
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complex.  The first intermediates arising from hydride transfer occurring in (58) could be 
either (59) or (60), both of which could react further to form an oxazadiboretane structure 
(61).  Cleavage of the latter would lead to the alkoxyborane (62) and regenerated catalyst. 
Ab initio calculations15q of the geometries and energies of these species support the 
validity of the proposed mechanism for transfer of the hydride from the borane group to 
the ketone moiety of the ketone-borane complex of an oxazaborolidine catalyst.  
However, the intermediate (59) appears not to represent a minimum on the potential 
energy hypersurface, but was found upon optimization either to undergo cleavage of the 
N-B bond of the oxazaborolidine ring to give (60), or to collapse into the 
oxazadiboretane system (61).  Computations show that the most likely reaction pathway 
followed by (61) is conversion to (60); elimination of the alkoxyborane moiety (62) and 
regeneration of the catalyst is apparently a higher energy pathway.  While the 
oxazadiboretane (61) is computed to be less stable than the ring-opened species (60), it 
has a significantly lower dipole moment and would therefore be predicted to be more 
soluble in non-polar solvents. 
(58)
(59) (60)
(61) (62)
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Scheme 21  Potential reactive intermediates
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While the oxazaborolidine system is usually regarded as a monomer, Corey et al16 have 
presented NMR evidence suggesting that the catalyst exists as a dimer.  This dimerization 
process has also been the subject of computational studies by Nevalainen.  Since the 
oxazaborolidine system contains two Lewis donor atoms (N and O) and one acceptor (B), 
three dimer structures are possible (Scheme 22), namely, N,N (64), N,O (65) and O,O 
(66). 
Ab initio calculations on simple models show that formation of N,N-adducts (64) is 
energetically more advantageous than the alternative N,O and O,O adducts.  However, as 
the actual heat of dimerization of oxazaborolidines is likely to be close to zero, in solution 
the monomer-dimer equilibrium would be sensitive to the chemical nature of the solvent 
and temperature. 
 
2.7.2 Modelling in the current study 
We decided to model selected oxazaborolidine-catalyzed borane reductions of 
acetophenone and phenacyl bromide (2-bromo-1-phenyl-ethanone) at the PM3 
semiempirical MO level of approximation.  Two oxazaborolidine systems (69) and (70) 
were investigated, the first derived from R-alaninol (67) and the second from R,S-
ephedrine (68), respectively.   
 
Scheme 22  Dimerisation of oxazaborolidine
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When BH3 and the ketone are allowed to coordinate with an oxazaborolidine, four 
configurations are possible in each case.  The conformational hyperspace associated with 
each configuration was explored and the heats of formation of the conformers that 
resulted were determined. 
 
The computed heat of formation of the most stable conformer (along with those others 
that contribute significantly) for each configuration are given in Table 13 and the 
Boltzmann populations in Table 14. 
 
Table 13.  Theoretical (PM3) heats of formation of the most stable conformations 
of the catalyst/BH3/ketone complexes. 
Ketone Heats of formation of complexes/kJ mol-1 
R R,R,R-(71) R,R,S-(71) R,S,R-(71) R,S,S-(71) 
CH3 -467.79 -484.33 -466.97 -443.53 
CH2Br -418.75 -434.93 -414.93 -407.93 
     R R,S,R,R-(72) R,S,R,S-(72) R,S,S,R-(72) R,S,S,S-(72) 
CH3 -300.72 -321.65 -333.05 -309.39 
CH2Br -249.42 -267.52 -279.49 -257.65 
 
 
N
B
O
Me Ph
O
HH3B
Me
PhC
     R
R,S,R,S-(72)
N
B
O
Me Ph
O
HH3B
Me
PhC
     R
R,S,S,R-(72)
N
B
O
Me Ph
O
HH3B
Me
PhC
     R
R,S,R,R-(72)
N
B
O
Me Ph
O
HH3B
Me
PhC
     R
R,S,S,S-(72)
N
B
O
Me
O
HH3B
H
PhC
     R
R,R,S-(71)
N
B
O
Me
O
HH3B
H
PhC
     R
R,S,R-(71)
N
B
O
Me
O
HH3B
H
PhC
     R
R,R,R-(71)
N
B
O
Me
O
HH3B
H
PhC
     R
R,S,S-(71)
 Page 2.23 
Table 14.  Theoretical (PM3) heats of formation and Boltzmann populations of 
catalyst/BH3/ketone complexes. 
Ketone Configurations and conformers 
R R,R,R-(71) R,R,S-(71) R,S,R-(71) R,S,S-(71) 
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CH3 -467.79 0.08 -484.33 64.2 -466.97 0.06 -443.53 0.00000
5 
   -481.12 35.2     
   -470.75 0.3     
         
CH2Br -418.75 0.1 -434.93 72.3 -414.93 0.02 -407.93 0.001 
   -432.06 22.7     
   -427.97 4.4     
   -420.24 0.2     
   -419.06 0.1     
         
R R,S,R,R-(72) R,S,R,S-(72) R,S,S,R-(72) R,S,S,S-(72) 
CH3 -300.72 0.0001 -321.65 0.5 -333.05 45.2 -309.39 0.003 
   -321.60 0.5 -331.13 20.8   
     -330.99 19.7   
     -328.29 6.6   
     -328.28 6.6   
         CH2Br -249.42 0.0003 -267.52 0.4 -279.49 49.7 -257.65 0.1 
     -279.11 42.8   
     -272.53 3.0   
     -270.71 1.4   
 
In the case of the R-alaninol derived oxazaborolidine (69), the R,R,S-configuration of the 
complex (71) is clearly the most stable, followed by R,R,R and R,S,R which are similar, 
and lastly R,S,S.  The relative stability of R,R,S-(71) can be attributed to two factors: 
(i) the trans relationship between the C(4)-CH3 and N-BH3 groups, which 
minimizes steric repulsions, and 
(ii) the cis relationship between the N-BH3 and B-OCPhR bonds where a 
favourable dipolar interaction occurs which is sufficiently strong to dominate 
any destabilizing steric repulsion. 
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The latter effect also explains the significantly greater stability of R,S,R-(71) compared 
with R,S,S-(71). 
 
The complexes based on the oxazaborolidine (70) are likely to experience greater steric 
congestion owing to the presence of additional ring substituents on the nitrogen atom and 
C(5).  The stability order for the complex (72) is (R,S,S,R) > (R,S,R,S) > (R,S,S,S) > 
(R,S,R,R), with the dipolar relationship between the N-BH3 and B-OCPhR bonds once 
again appearing to be the determining factor.  It seems that the steric interaction between 
the C(4)-CH3 and N-BH3 groups is a secondary factor in this system since the presence 
of the N-CH3 group reduces the energy difference between the cis and trans 
configurations about the N-C(4) bond. 
 
During the conformational searches carried out on each of the configurations of the 
complexes (71) and (72) described above, a number of variants were found in each case, 
arising from variations in the orientation of the ketone group with respect to the rest of the 
structure.  The structures R,R,S-(71)-a - R,R,S-(71)-d shown below illustrate some of the 
different arrangements that are obtained. 
 
The various configurations and their conformers obtained, along with their relative 
energies, can be tabulated in detail as illustrated in Table 15 for the oxazaborolidine 
(69)/BH3/acetophenone complex. 
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Table 15.  Theoretical enantioselectivity for the BH3 reduction of PhCOCH3 in the 
presence of oxazaborolidine (69). 
C
on
fi
gu
ra
tio
n 
 C
on
fo
rm
er
 
R
el
at
iv
e 
en
er
gy
/ 
kJ
 m
ol
-1
 
M
ol
e 
fr
ac
tio
n 
E
ac
t/k
J 
m
ol
-1
* 
k/
s-
1  
Y
ie
ld
 o
f 
pr
od
uc
t/%
 
C
on
fi
gu
ra
tio
n 
of
 
pr
od
uc
t 
R,R,S 1 0.00 6.42E-01 22.1 1.31E-04 60.87 S 
R,R,S 2a 3.21 1.76E-01 20.8 2.25E-04 28.63 S 
R,R,S 2b 3.21 1.76E-01 23.8 6.73E-05 8.56 S 
R,R,S 3a 13.58 2.67E-03 17.9 7.42E-04 1.43 R 
R,R,S 3b 13.58 2.67E-03 20.6 2.46E-04 0.48 R 
R,R,R 4 16.55 8.09E-04 58.0 6.74E-11 <0.01  
R,S,R 5 17.36 5.82E-04 23.2 8.49E-05 0.04 S 
R,R,R 6 23.72 4.47E-05 56.7 1.17E-10 <0.01  
R,R,R 7 27.79 8.66E-06 57.7 7.59E-11 <0.01  
R,S,R 8 36.79 2.30E-07 17.1 9.90E-04 <0.01  
R,R,R 9 40.46 5.23E-08 49.7 1.93E-09 <0.01  
R,S,S 10 40.80 4.55E-08 57.5 8.46E-11 <0.01  
R,S,S 11 40.98 4.25E-08 43.7 2.20E-08 <0.01  
     ee 96.2 S 
* The values of Eact shown are those obtained for the fully refined transition state structure as described 
below. 
 
It can be assumed that the collection of conformers obtained in this way will take up a 
Boltzmann distribution based on their relative energy differences.  Hence, the population 
probability Pi of a conformer i of energy Ei at a temperature T can be calculated from the 
expression: 
where k is the Boltzmann constant.  Where there are n conformers involved, the 
population probability for each conformer can be expressed as a mole fraction by 
applying the equation: 
å -
-
= n
i
kTE
kTE
i
i
i
e
e
P
/
/
 
The energy profile associated with the transfer of hydride from the N-BH3 moiety to the 
carbon atom of the complexed ketone can then be determined by incrementally reducing 
kTE
i
ieP /-=
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the distance between the migrating hydrogen on BH3 and the C-atom and calculating the 
heat of formation of each such structure* (e.g., see Fig. 6).  
Fig. 6  Energy Profile for H-transfer in (R ,R ,S  71)-c
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Generally, the energy rises smoothly to a maximum and then drops as the transfer is 
completed and the new structure relaxes.  Also shown in Fig. 6 is the change in the CO---
B bond length where it is found to shorten as the H-transfer proceeds, reflecting the 
buildup in negative charge on the ketone oxygen atom. 
 
The structure of the transition state associated with the hydride transfer is expected to 
resemble the geometry found at the highest point of the energy curve.  Hence the 
difference between the heats of formation of the equilibrium starting complex and the 
structure at the energy maximum can be assumed to represent the activation energy (Eact) 
for the hydride transfer process. 
 
Knowledge of Eact makes it possible to calculate a theoretical rate constant k for the 
reaction from the Arrhenius relationship: 
 
                                                 
* In cases where a second incipient hydride ion is suitably positioned for migration, the 
energy profile for its migration is also determined.  This is the case for conformers 2a and 
2b, and 3a and 3b in Table 15. 
RTEactek -=
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Since the mole fraction of each conformer of the various oxazaborolidine/BH3/ketone 
complexes is known, as well the rate constant associated with its H-transfer reaction 
(which is a unimolecular process), the yield of product expected from each conformer can 
be estimated and is shown in Table 15.  The configuration of the incipient alcohol that 
results can easily be determined and hence the theoretical enantiomeric excess (ee) 
associated with the reduction of the ketone can be calculated.  In the case of the reaction 
whose data is given in Table 15 the theoretical ee is 99.0% in favour of the S-
configuration of the alcohol.  The theoretical enantioselectivities calculated for the BH3 
reduction of acetophenone and phenacyl bromide in the presence of the catalysts (69) and 
(70) are summarized in Table 16.  The product configuration predicted for the ephedrine 
based catalyst reaction is in agreement with our earlier experimental results (Table 7), 
while that obtained for the alaninol reaction is not. 
 
Table 16.  Theoretical enantioselectivities for the BH3 reduction of 
PhCOCH3 and PhCOCH2Br in the presence of catalysts (69) and (70). 
Ketone Catalyst ee (theoretical) Configuration 
PhCOCH3 (69) 99.0 S 
  96.2* S 
PhCOCH3 (70) 98.3 R 
PhCOCH2Br (69) 91.4 R 
PhCOCH2Br (70) 96.7 S 
* Enantioselectivity calculated for refined transition state structures. 
 
In one series of reactions [i.e., the complex (69)/BH3/PhCOCH3] the structures 
corresponding with the energy maximum on the curve obtained for H-transfer in each 
case were subjected to further geometry refinement at the PM3 level, where they were 
characterized fully as transition state structures through ensuring that each gave rise to 
only a single imaginary vibrational frequency.  Furthermore, in each case the process 
associated with the imaginary vibration was animated in order to confirm that it 
corresponded with the H-transfer step.  The energies of these refined transition state 
structures were then used to recalculate Eact in each case and hence the enantioselectivity 
of the reduction.  The ee of 96.2% obtained in this way is slightly lower than that 
predicted from the cruder approach described earlier.   
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Since this refinement procedure is computationally more expensive, it was not extended 
to the other systems.  However, it is highly likely that the enantioselectivity will remain 
qualitatively the same in each case, while the theoretical ee could show variations. 
 
It is clear that the computed values for Eact for those configurations where the N-BH3 and 
complexed ketone groups are trans are substantially greater than for when they are cis.  
As a result, the relative rate constants obtained for H-transfer in the trans configurations 
are negligibly small in comparison with those obtained for the cis configurations and 
contributions from the trans configurations can generally be neglected. 
 
In some cases, the potential energy profiles associated with H-transfer are found to 
display step-wise changes in energy as the H---CO bond is shortened (see Fig. 7). 
Fig. 7  Illustration of a step-wise energy change during H-transfer in 
(R ,R ,S  71)
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These energy changes are usually associated with bond rotations, especially in the 
OC-CH3 or OC-CH2Br bond of the ketone which result in the complexes relaxing to 
lower energy conformers. 
 
When the structures of the complexes are examined closely, it becomes apparent that in 
some instances there are stabilising interactions between one of the BH3 hydrogens and 
either an acidic carbonyl a-hydrogen, or even a phenyl ortho hydrogen.  For example, in 
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the most stable conformer of the complex (R,R,S)(71) (R = CH3), the BH3 hydrogen best 
positioned for transfer to the carbonyl group is located 2.92 Å from the carbonyl carbon 
atom, while a second BH3 hydrogen lies only 1.68 Å from a carbonyl a-proton.  The 
interaction is reflected in the Mulliken charge computed for the methyl hydrogen 
involved which is 0.16, compared with values of 0.08 and 0.09 for the other two. 
 
It therefore seemed prudent to explore the possibility of a competing acid-base reaction 
taking place, leading to the liberation of H2.  The energetics of the process were 
investigated.  The reactions are outlined in Scheme 23, with (74) and (76) representing 
the transition state structures for the reduction and acid-base reactions, respectively.  The 
computed heats of formation of the various structures are given in Table 17. 
N
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H H
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Scheme 23 
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Table 17  Computed energies of structures (73)-(79) 
 DHf/kJ mol-1 DDHf*/kJ mol-1 k/s
-1 Product yield/% 
(73) -484.4    
(74) -462.2 22.2 1.3 ´ 10-4 94.1 
(75) -537.7 -53.3   
(76) -455.3 29.0 8.2 ´ 10-6 5.9 
(77) -511.4 -27.1   
(78) -616.9 -132.6   
(79) -585.1 -100.8   
* Relative to structure (73). 
 
It is clear that the reduction process is significantly more exothermic than a-H 
abstraction.  Furthermore, the activation energy for reduction is lower than that for H-
abstraction with the result that the theoretical rate constant for the former process is about 
16 times larger than that for the latter.  Clearly the reduction process will dominate H-
abstraction at 298K. 
 
The calculations show that if the complexed enolate (77) were to undergo cyclisation, a 
substantially more stable compound (78) would result; the isomer (79) is less stable than 
(78). 
 
Our results demonstrate that simple modelling experiments of the kind described above 
are able to predict the enantioselectivity of an oxazaborolidine catalysed BH3 reduction of 
a ketone.  This method can therefore be used as a tool for assessing the enantioselectivity 
likely to arise in the presence of any catalyst, and can assist in the design of new, 
improved catalysts.  
 
2.8 Conclusions  
A six-step synthesis of salbutamol from methyl salicylate with an overall yield of 17% 
has been completed; the yield was not optimised.  In the process, Zn(BH4)2 was found to 
be a suitable reducing agent and selectively reduced the ketone group of the keto ester 
(52).  In contrast, borane was found to reduce both the ketone and ester carbonyl groups. 
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Reduction of phenacyl bromide with borane in the presence of chiral catalysts based on 
(R)-alaninol and (R,S)-ephidrine resulted a measure of enantioselectivity.  However, the 
configuration of the alcohol obtained in the case of (R)-alaninol was contrary to 
expectations based both on experimental trends observed elsewhere as well as our own 
theoretical predictions.  Clearly, this anomaly should be investigated further in the future. 
 
The asymmetric reduction of methyl 5-bromoacetyl-2-benzyloxybenzoate (52) was 
carried out with both borane and Zn(BH4)2 in the presence of a range of chiral catalysts.  
Optically active products were obtained in all cases, although the rotations were 
significantly smaller in the case of Zn(BH4)2.  Unfortunately, we were not successful in 
determining the ee’s of these reactions.  The use of a NMR lanthanide shift reagent 
resulted in a complex spectrum that was impossible to interpret unambiguously.  This 
presumably arises from the presence of several sites in the product (55) at which 
complexation can take place.  This factor could complicate other approaches such as the 
use of chiral derivatising agents (e.g., Mosher’s reagent) followed by NMR analysis.  
However, this and other methods for the determination of the ee’s17 will have to be 
explored in future work.  Also note that it was not possible to determine the optical 
rotation of salbutamol itself owing to the relatively small amount of material obtained. 
 
The conformational analysis of salbutamol, where NMR data was correlated with 
molecular modelling results, was successful and revealed a strong preference for that 
conformer family characterised by O–C–C–N and Ar–C–C–N torsion angles of ca. 60º 
and 180º, respectively.  Interestingly, these conformers are stabilised by OH…N rather 
than NH…O hydrogen bonding.  This study has also confirmed the effectiveness of the 
MMFF94 force field for conformational analysis studies. 
 
Lastly, we implemented a relatively simple method for modelling the BH3/ 
oxazaborolidine reduction of ketones at the PM3 semiempirical MO level of 
approximation.  This approach has provided insights into the mechanism of the reaction 
and has furthermore enabled us to predict the enantioselectivities likely to result from 
various catalysts and ketones.  In comparing our theoretical and experimental findings, an 
anomalous result was obtained in the case of (R)-alaninol; this will have to be 
investigated further, particularly at the experimental level.  However, we believe that our 
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approach provides a sound basis for aiding the design and screening of new, potentially 
better catalysts. 
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3. EXPERIMENTAL 
 
3.1 General 
Melting points were recorded on an Electrothermal 1A 9000 Series digital melting point 
apparatus and are uncorrected. 
 
Infrared spectra were recorded on a Perkin Elmer 1600 Series Fourier Transform infrared 
spectrophotometer. 
 
1H-NMR and 13C-NMR spectra were recorded on a Bruker Avance 300 MHz NMR 
spectrometer. 
 
Optical rotations were determined using an Atago Polax-D Polarimeter equipped with a 
sodium lamp of which the D-line at 589nm was used as the light source. 
 
Microdistillations were carried out in a Büchi GKR-50 microdistillation apparatus. 
 
Aluminium oxide (neutral, Brockman Grade I) was used in column chromatography. 
Preparative thin layer chromatography was performed on a model 7924T Harrison 
Chromatotron utilising silica gel 60 PF-254 as adsorbent with calcium sulphate as binder. 
 
Most of the organic compounds whose syntheses are described below have been 
previously prepared and characterised in these laboratories.  The compounds were thus 
identified through comparison with authentic materials. 
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3.2 Preparation of Anhydrous Solvents 
3.2.1 Benzene 
Benzene was allowed to stand over sodium wire after which it was distilled (b.p. 80 
oC/760 mmHg).  The distillate was stored over Type 5Å molecular sieve. 
 
3.2.2 Chloroform (CHCl3) 
Chloroform was refluxed over CaCl2 and then stored over Type 4Å molecular sieve. 
 
3.2.3 Dichloromethane (CH2Cl2) 
(i) Dichloromethane was refluxed over anhydrous calcium chloride and then distilled. 
Dry dichloromethane was stored with protection from light in a dark bottle 
containing Type 3Å molecular sieve. 
(ii) Dichloromethane was also dried over sodium wire. 
 
3.2.4 Diethyl ether 
Diethyl ether was dried over sodium wire. 
 
3.2.5 Ethanol (EtOH) 
Ethanol was stored over Type 4Å molecular sieve. 
 
3.2.6 Ethyl methyl ketone (MEK) 
MEK was refluxed over anhydrous K2CO3 before being distilled (b.p.79-80 oC). 
 
3.2.7 Petroleum ether and hexane 
Petroleum ether and hexane were stored over sodium wire. 
 
3.2.8 Tetrahydrofuran (THF) 
THF was refluxed over sodium and benzophenone until a blue colour was observed, and 
then distilled (b.p. 65-66 oC) and kept over sodium wire. 
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3.3 Syntheses 
3.3.1 Zinc borohydride1,2 
Method 1 
Anhydrous ZnCl2 (18 g; 125 mmol) was fused by heating under a nitrogen atmosphere in 
a 500 ml three-necked round-bottomed flask.  A solution of NaBH4 (11 g, 291 mmol) in 
250 ml dry THF was introduced into the flask through a rubber septum.  The contents 
were stirred at room temperature for 72 h.  The clear supernatant layer containing the 
Zn(BH4)2 was stored in a refrigerator for a later use.  It can be kept under nitrogen at room 
temperature for six months. 
 
Method 2 
Sodium borohydride (1.95 g, 52.2 mmol) was dissolved in redistilled dimethoxyethane 
(50 ml).  Recently fused ZnCl2 (3.4 g, 24.9 mmol) was added into the solution with 
continuous stirring at (0-5) oC with stirring continuing overnight. The solution was then 
filtered under nitrogen. The clear solution of Zn(BH4)2 was used immediately. 
 
3.3.2 Borane3 
The central neck of a 250 ml round-bottomed two-necked flask (the generating flask), 
supported on a magnetic stirrer was fitted with a pressure-equalising dropping funnel 
connected to a nitrogen supply via a suitable mercury safety valve.  The side-neck of the 
generating flask was connected to a Dreschel wash-bottle with a polyethylene tube, the 
outlet of which led into a 250 ml two-necked round-bottomed flask (the receiving flask) 
via a gas inlet tube terminating in a glass frit.  The receiving flask was charged with 100 
ml of dry tetrahydrofuran and the second neck was closed with a calcium chloride guard-
tube.  Sodium borohydride (3.33 g, 8.80 mmol) was dissolved in 87.5 ml of dry diglyme 
and placed in the dropping funnel.  Redistilled boron trifluoride diethyl etherate  (21.3 g, 
150.0 mmol) was placed in the generating flask containing a magnetic follower bar.  
Nitrogen was allowed to pass through the assembly for a period of about 15 minutes to 
displace all the air.  Adding the sodium borohydride solution steadily to the stirred boron 
trifluoride diethyl etherate resulted in the generation of borane.  When all the solution had 
been added, the passage of nitrogen gas was continued for a further 15 minutes to ensure 
that all the borane had been swept into the THF solution.  The resulting THF solution is 
 Page 3.4 
approximately 1M with respect to borane. The solution is reasonably stable if stored 
between 0-5 oC    
 
3.3.3 1-Phenylethanol 
Method 1 
A solution of Zn(BH4)2 in THF (3.8 ml, mmol) was added to a stirred solution of  
acetophenone (1.0 g, 8.32 mmol) dissolved in dimethoxyethane (7.5 ml), and stirring was 
continued overnight at room temperature.  Dil. HCl was used to quench the reaction.  The 
organic layer was separated whilst the aqueous layer was extracted with diethyl ether (3 x 
20 ml). The combined DME and ether extracts were dried with anhydrous Na2SO4. The 
solution was concentrated to give 1-phenylethanol (0.96 g, 96 %). 
 
Method 2 
A solution of borane in THF (1.50 ml, 1.0 M, 1.50 mmol) was cooled in a ice bath 
whereupon acetophenone (1.7 ml, 15 mmol) was added slowly.  The temperature of the 
solution was then raised to 30 oC and the mixture allowed to stir for 3h.  The reaction 
mixture was then treated with dil. HCl and extracted with CH2Cl2. After washing 
successively with dil. NaOH and aqueous NaCl, the combined organic extracts were dried 
over Na2SO4 and concentrated to afford 1-phenylethanol (1.69 g, 92 %). 
 
3.3.4 2-Bromo-1-phenylethanol 
A solution of Zn(BH4)2 in THF (2.97g, 31.3 mmol) was added to a solution of 
bromoacetophenone (0.6 g, 3.13 mmol)  in dimethoxyethane (4.5 ml).  The mixture was 
stirred at room temperature overnight before the reaction was quenched with 0.5N HCl. 
The organic layer was separated whilst the aqueous layer was extracted with diethyl ether 
(3 x 20ml).  The combined DME and ether extracts were dried with anhydrous Na2SO4. 
Removal of the organic solvents under reduced pressure gave 2-bromo-1-phenylethanol 
(0.52 g, 83 %), dH(CDCl3) 1.80 (1H, br, OH), 3.52 (2H, m, CH2Br), 4.89 (1H, m, CH) and 
7.06-7.98 (5H, m, Ar-H); dC(CDCl3) 29.0 (CH2Br), 68.4 (CH) 128.6 (Ar), 129.1 (Ar), 
134.3 (Ar) and 140.8 (Ar). 
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3.3.5 (1S)-(+)-10-Camphorsulfonyl chloride 
Phosphorus pentachloride (10.8 g, 51.5 mmol) was added to (1S)-(+)-10-camphor-
sulfonic acid (10 g, 40 mmol) in a three-necked round-bottomed flask connected to an 
efficient hydrogen chloride trap.  The reaction mixture was allowed to stir overnight 
before the reaction was quenched with ice-cold water and the pH of the mixture adjusted 
to 7.  The product was extracted with ether (100 ml) and the extracts dried over 
anhydrous Na2SO4 and concentrated under reduced pressure to afford (1S)-(+)-10-
camphorsulfonyl chloride as white crystals (6.4 g, 68 %), m.p. 80-83 oC (lit. m.p. 81-84 
oC); dH(CDCl3) 0.99 (3H, s, CH3), 1.15 (3H, s, CH3), 1.25 (2H, t, CH2),  
 
3.3.6 1-Phenylethyl camphorsulfonate 
1-Phenylethanol (0.84 g, 6.90 mmol) was dissolved in chlorofo rm (60 ml) and the 
solution cooled in an ice bath.  Pyridine (17.8 ml, 13.8 mmol) was added, followed by the 
slow addition of a solution of (1S)-(+)-10-camphorsulfonyl chloride (5.2 g, 20.7 mmol) in 
chloroform (10 ml). The mixture was stirred for 3 h, while the progress of the reaction 
was monitored by thin layer chromatography.  Ether (30 ml) and water (7 ml) were added 
to the reaction mixture and the organic layer separated.  The organic layer was washed 
successively with 2M hydrochloric acid (2 ml), 5% sodium hydrogen carbonate and water 
before being dried over sodium sulfate.  The solvent was removed under reduced pressure 
to yield 1-phenylethyl camphorsulfonate as a white oil (1.74 g, 75 %), nmax (CHCl3)/cm-1 
1742 (s, C=O), 1372.5 (s, -SO3-); dH(CDCl3) 0.85 (3H, s, CH3), 1.08 (3H, s, CH3), 1.50 
(1H, dd, CHcHd), 1.75 (1H, dd, CHcCHd) 1.77 (3H, d, CH3), 2.1-2.24 (2H, m, CH2), 
2.40(2H, d, CH2), 3.75 (1H, dd, CHaCHb), 4.35 (1H, dd, CHaCHb), (1H, q, CH) and 7.25-
7.55 (5H, m, Ar-H); dC(CDCl3) 20.03 (CH3), 20.09 (CH3), 25.71 (CHcHd), 26.13 (CH3), 
27.28 (CH2), 42.72 (CH2), 43.16 (CH), 48.68 (CH), 59.27 (CH), 64.76 (CH),126.93 
(quaternary-C), 127.81 (Ar), 129.05 (Ar), 143.19 (Ar) and 213.20 (C=O). 
 
3.3.7 10-Mercapto-iso-borneol 
Lithium aluminium hydride (1.4 g, 37 mmol) was suspended in dry ether (50 ml) 
whereupon a solution of (+)-camphor-10-sulfonyl chloride (6.25 g, 249 mmol) in ether 
(50 ml) was slowly added at 0 oC under nitrogen.  The mixture was allowed to warm to 
room temperature after which it was refluxed overnight.  The reaction was then quenched 
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with ethyl acetate followed by dil. HCl (ca. 1-2%).  The resulting mixture was filtered 
and the filtrate washed with brine to neutrality.  The organic layer was separated and 
dried over Na2SO4.  The oil resulting from concentration was chromatographed on silica 
gel using hexane-EtOAc (98:2) as eluent.  Two fractions were obtained.  The first fraction 
gave 10-mercapto-iso-borneol as a white solid (3.14 g, 46 %), m.p. 69-73 oC (lit. m.p. 70-
72 oC); nmax(CHCl3)/cm-1 3450 (s, free OH), 2500 (w, SH); dH(CDCl3) 0.85 (3H, s, CH3), 
1.08 (3H, s, CH3), 1.24 (2H, m, CH2), 1.49 (2H, m, CH2) 1.66 (2H, m, CH2), 1.77 (2H, m, 
CH2), (1H, s, OH), 2.51 (1H, dd, CH), 2.79 (1H, dd, CH) and 3.97 (1H, t, CH); 
dC(CDCl3) 19.9 (CH3), 20.6 (CH3), 23.5 (CH2), 26.7 (CH2), 30.3 (CH2), 39.4 (CH2), 45.7 
(CH), 47.4 (CH), 52.9 (CH) and 78.9 (CH). 
 
3.3.8 (-)-(1R,2R,4S)-1-Methyl-4-(1-methylethenyl)-2-(4-morpholinyl)cyclohexanol 
A 250 ml, single-necked flask equipped with a magnetic stirrer bar and a reflux condenser 
and a nitrogen bubbler was charged with  (+)- limonene oxide* (5.48 g, 36 mmol), 
morpholine (9 ml, 103 mmol) and deionised water (1 ml) and the mixture refluxed for 72 
h.  The flask was then cooled and the excess morpholine and limonene oxide distilled off 
at 39 oC under reduced pressure (10 mbar) to yield the crude amino alcohol as dark 
orange, viscous oil (6.43 g).  The crude product was dissolved in methanol (9 ml) to 
which a solution of oxalic acid (3.30 g, 37 mmol) was added with stirring.  The heavy 
slurry that formed was cooled in an ice bath and stirred for 30 min. The solid was isolated 
by filtration, air-dried and then washed with ice-cold methanol (7.5 ml).  The resulting 
oxalate salt of (-)-(1R,2R,4S)-1-methyl-4-(1-methylethenyl)-2-(4-morpholinyl)cyclo-
hexanol was obtained as a white solid  (5.46 g), mp 205-207 oC.  The salt was transferred 
to a separating funnel and mixed with 1N KOH (60 ml) and diethyl ether (20 ml).  The 
mixture was shaken and the layers separated.  The aqueous layer was extracted further 
with diethyl ether (3 x 20 ml).  The combined ether extracts were washed with deionised 
water (10 ml) and dried over anhydrous sodium sulfate.  The ether solution was removed 
on a rotary evaporator leaving (-)-(1R,2R,4S)-1-methyl-4–(1-methylethenyl)-2-(4-
morpholinyl)cyclohexanol (3.56 g, 42 %) as pale yellow oil. 
 
 
 
                                                 
* Supplied by Aldrich Chemical Company as a mixture of cis and trans isomers. 
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3.3.9 Methyl 5-acetyl-2-hydroxybenzoate 
Methyl salicylate (15 ml, 116 mmol) was dissolved in dry CH2Cl2 together with acetic 
anhydride (15 ml, 148 mmol).  Aluminium chloride (60 g, 450 mmol) was added to the 
mixture at such a rate so as to maintain a gentle refluxing.  The mixture was then heated 
to reflux for a further 16 h before being cooled.  The reaction was quenched by pouring 
the mixture into an ice-water slurry and the organic layer was separated.  The aqueous 
layer was extracted with of CH2Cl2 (3x100ml).  The organic layers were combined and 
dried over anhydrous sodium sulphate.  Removal of the solvent on a rotary vapour gave a 
solid which was recrystallized from CH2Cl2/ hexane to yield white crystals of methyl 5-
acetyl-2-hydroxybenzoate (21.0 g, 92.2 mmol, 80 %), m.p. 61.3-64.7oC (lit. m.p. 62-
64oC); ?max (CHCl3)/cm-1 3245 (br w, phenolic OH), 1708 (s, C=O) and 1681 (s, C=O); 
dH(CDCl3) 2.54 (3H, s, COCH3), 3.97 (3H, s, COOCH3), 6.99 (1H, d, J = 8.8 Hz, 3-H of 
Ar-H), 8.04 (1H, dd, J1 = 8.8 Hz, J2 = 2.3 Hz, 4-H of Ar-H), 8.43 (1H, d, J = 2.3 Hz, 6-H 
of Ar-H) and 11.20 (1H, s, phenolic OH); dC(CDCl3) 28.2 (COCH3), 54.7 (COOCH3), 
114.0 (quaternary Ar-C), 119.9 (Ar-C), 131.0 (quaternary Ar-C), 133.4 (Ar-C), 137.4 
(Ar-C), 167.2 (quaternary Ar-C), 172.1 (COOCH3) and 197.8 (COCH3). 
  
3.3.10 Methyl 5-(a-bromoacetyl)-2-hydroxybenzoate) 
A solution of bromine (4.12 g, 25.7 mmol) in CHCl3  (125 ml) was added to a solution of 
methyl 5-acetyl-2-hydroxybenzoate (5 g, 25.7 mmol) in CHCl3 (50 ml) with the 
temperature maintained at 33-35 oC.  When no further decolourisation occurred, the 
addition of bromine was stopped and the reaction mixture stirred for a further 5 min 
whereupon it was poured into ice-water slurry. The organic layer was separated, washed 
with water (4 x 400 ml), it was dried (anhydrous Na2SO4) and then concentrated. The 
resulting product was then recrystallized from CHCl3/hexane to yield white crystals of 
methyl 5-(a-bromoacetyl)-2-hydroxybenzoate (5.67 g, 24.4 mmol, 97 %), m.p. 87.6-94.0 
oC; ?max(CHCl3)/cm-1 3221 (br w, phenolic OH), 1713 (s, C=O) and  1691 (s, C=O); 
dH(CDCl3) 3.99 (3H, s, COOCH3), 4.39 (2H, s, CH2Br), 7.03 (1H, d, J = 8.8 Hz, 5-H of 
Ar-H), 8.08 (1H, dd, J1 = 8.8 Hz, J2 = 2.3 Hz, 6-H of Ar-H), 8.49 (1H, d, J = 2.3 Hz, 2-H 
of Ar-H) and 11.31 (1H, s, phenolic OH); dC(CDCl3) 32.37 (CH2Br), 54.8 (COOCH3), 
114.3 (quaternary Ar-C), 120.4 (Ar-C), 127.6 (quaternary Ar-C), 134.1 (Ar-C), 138.0 
(Ar-C), 167.8 (quaternary Ar-C), 171.8 (COOCH3) and 191.2 (COCH2Br). 
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3.3.11 Attempted preparation of methyl 5a-(N-tert-butylbenzylamino)acetyl-2-hydroxy-
benzoate 
 
Methyl 5-(a-bromoacetyl)-2-hydroxybenzoate (5.00 g, 18.3 mmol) and N-benzyl-N-tert-
butylamine (6.00 g, 37.1 mmol) were stirred together in butanone (50 ml) at room 
temperature for a week.  Workup afforded a brown solid whose NMR spectrum revealed 
the presence of a complex mixture.  The preparation was abandoned. 
 
3.3.12 Methyl 5-acetyl-2-benzyloxybenzoate 
Method 1 
Sodium hydride (0.744 g, 31mmol; 50% oil) was placed in a 500 ml round bottom flask 
and washed thrice with dry petroleum ether (40-60 oC) and twice with dry hexane.  The 
hexane was then removed and dry DMF (125 ml) was added to the flask.  A solution of 
methyl 5-acetyl-2-hydroxybenzoate (5.00 g, 26.0 mmol) in DMF (50 ml) was added 
slowly to the NaH suspension through a septum.  After the evo lution of hydrogen gas had 
ceased, the reaction mixture was stirred at 25 oC for 1 hour before benzyl bromide (3.70 
ml, 30 mmol) was added. The reaction mixture was stirred at 25 oC for a further 12 h. The 
excess NaH was destroyed by addition of water. The product was then extracted with dry 
CHCl3 (3 x 250 ml). The combined organic layers were dried over anhydrous Na2SO4, 
concentrated and the DMF removed by distillation under reduced pressure.  A quantity of 
hexane was added to the residue and refluxed for 1 h.  The hexane was decanted, 
concentrated, and cooled to give yellow crystals of methyl-3-acetyl-2-benzyloxybenzoate 
(4.85 g, 18 mmol, 63%); m.p. 66.3-67.9 oC.  The NMR and IR data are given with 
Method 2 below. 
 
Method 2 
Methyl 5-acetyl-2-hydroxybenzoate (10.0 g, 51.6 mmol), benzyl bromide (6.16 ml, 51.6 
mmol), anhydrous K2CO3 (42.78 g, 310 mmol) and NaI (46.50 g, 310 mmol) were added 
to acetone (500 ml) in a 1 l round-bottomed flask.  The mixture was refluxed for about 16 
h whereupon the reaction was quenched with water (500 ml) and then extracted with 
CHCl3 (3 x 500 ml).  The combined organic layers were dried over anhydrous Na2SO4 
and then concentrated.  The resulting solid was recrystallized from CHCl3/hexane to yield 
yellow crystals of methyl 5-acetyl-2-benzyloxybenzoate (13.01 g, 45.7 mmol, 89 %); 
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?max(CHCl3)/cm-1 1725 (s, C=O) and 1679 (s, C=O); dH(CDCl3) 2.59 (3H, s, COCH3), 
3.94 (3H, s, COOCH3) 5.27 (2H, s, CH2Ph), 7.07 (1H, d, J = 8.8 Hz, 5-H of Ar-H) 7.39 
(5H, m, CH2C6H5), 8.08 (1H, dd, J1 = 8.8 Hz, J2 = 2.3 Hz, 6-H of Ar-H) and 8.47 (1H, s, 
3-H of Ar-H); dC(CDCl3) 26.8 (COCH3) 52.7 (COOCH3) 71.0 (CH2Ph) 113.7 (Ar-C) 
120.8 (quaternary Ar-C), 127.1 (Ar-C), 128.5 (Ar-C), 129.1 (Ar-C), 130.2 (quaternary 
Ar-C), 133.2 (Ar-C), 134.1 (Ar-C) 136.3 (quaternary Ar-C) 162.0 (quaternary Ar-C), 
166.3 (COOCH3) and 196.5 (COCH3). 
 
3.3.13 Methyl 5-(a-bromoacetyl)-2-benzyloxybenzoate 
A solution of bromine (1.80 m1, 35.0 mmol) in CHCl3 (250 ml) was added slowly to a 
solution of methyl 5-acetyl-2-benzyloxybenzoate (10g, 35.2 mmol) in CHCl3 (100 ml) to 
yield brown solid after workup.  The solid was recrystallized from CHCl3/hexane to give 
the product as white crystals (8.02 g, 22.1 mmol, 62 %); ? max (CHCl3)/cm-1 1728 (s, 
C=O) and 1628 (s, C=O); dH(CDCl3) 3.94 (3H, s, COOCH3) 4.42 (2H, s, COCH2Br), 5.29 
(2H, s, CH2Ph) 7.10 (1H, d, J = 8.8 Hz, 5-H of Ar-H) 7.39 (5-H, m, CH2C6H5), 8.10 (1H, 
dd, J1 = 8.8 Hz, J2 = 2.4 Hz, 6-H of Ar-H) and 8.47 (1H, s, 3-H of Ar-H) dC(CDCl3) 30.8 
(CH2Br), 52.8 (COOCH3), 71.1 (CH2Ph), 113.9 (Ar-C), 121.2 (quaternary Ar-C), 126.8 
(quaternary Ar-C), 127.1 (Ar-C), 128.6 (Ar-C), 129.1 (Ar-C),133.7 (Ar-C), 134.9 (Ar-C), 
136.1 (Ar-C) 137.3 (quaternary Ar-C), 162.6 (quaternary Ar-H), 166.0 (COOCH3) and 
189.8 (COCH2Br). 
 
3.3.14 Attempted synthesis of methyl 5-(a-N-tert-butylaminoacetyl)-2-benzyloxy-
benzoate 
 
Methyl 5-(a-bromoacetyl)-2-benzyloxybenzoate (1 g, 2.75 mmol) was dissolved in an 
excess of distilled tert-butylamine and the solution refluxed for seven days.  The excess 
tert-butylamine was distilled off under reduced pressure.  The residue was then dissolved 
in dichloromethane before being washed with 3N sodium hydroxide followed by water. 
The organic layer was dried with Na2SO4 and concentrated to yield a brown oil.  A 1H-
NMR spectrum revealed the presence of complex mixture. The preparation was 
abandoned. 
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3.3.15 Attempted synthesis of methyl 3-(a-N-benzyl-N-tert-butylaminoacetyl)-2-
benzyloxy-benzoate 
 
Methyl 5-(a-bromoacetyl)-2-benzyloxybenzoate (0.60 g, 1.65 mmol) was dissolved in an 
excess N-benzyl-N-tert-butylamine and the solution refluxed fo r 4h.  The excess N-
benzyl-N-tert-butylamine was distilled off under reduced pressure.  The residue was then 
dissolved in dichloromethane before being washed with 3N sodium hydroxide followed 
by water.  The organic layer was dried over Na2SO4 and concentrated to give a brown oil.   
A 1H-NMR spectrum showed the presence of a complex mixture.  The preparation was 
abandoned. 
 
3.3.16 Methyl-2-benzyloxy-5-(2-bromo-1-hydroxyethyl)benzoate 
Zn(BH4)2 (2.95 g, 31.5 mmol) was transferred into a two-necked 100 ml round-bottomed 
flask which was purged with nitrogen gas and then cooled in an ice bath.  Thereafter, a 
solution of methyl-2-benzyloxy-5-bromoacetylbenzoate (1.14 g, 3.15 mmol) in 
dimethoxyethane (20 ml) was added slowly.  After 4 h the reaction was quenched with 
0.5 N HCl and the organic layer separated and kept aside.  The aqueous layer was 
extracted three times with diethyl ether.  The organic layers were combined and washed 
with 0.5 N NaOH and 5 % NaCl solution, respectively.  After drying with anhydrous 
Na2SO4 the solution was concentrated to give a yellow oil of methyl-2-benzyloxy-5-(2-
bromo-1-hydroxyethyl)benzoate:(0.92 g, 80 %), n max(CHCl3)/cm–1 3524 (s, free OH), 
3493 (br, OH) and 1730 (s, C=O); dH(CDCl3) 3.13 (1H, br s, OH), 3.37 (1 H, dd, J1=10.4, 
J2=8.3, CHaCHbBr),3.44 (1H, dd, J1 = 10.5, J2 = 4.0, CHaHbBr),3.77 (3H, s, COOCH3), 
4.73 (1H, dd, J1 = 8.2, J2 = 3.8 CH), 5.04 (2H, s, CH2Ph), 6.85 (1H, d, J = 8.7, Ar- H), 
7.15 – 7.40 (6H, m, Ar – H) and 7.69 (1H, d, J = 2.33, Ar – H); dC(CDCl3) 38.5 (CH2Br), 
51.1 (COOCH3), 69.6 (CH2Ph), 71.8 (CH), 112.9 (Ar), 119.4 (quaternary-Ar),125.8 (Ar), 
126.8 (Ar),127.5 (Ar), 128.5 (Ar), 130.1 (Ar), 131.8 (quaternary-Ar), 135.5 (Ar), 156.9 
(Ar) and 165.5 (COOCH3). 
 
3.3.17 1-(4-Benzyloxy-3-hydroxymethyl-phenyl)-2-bromo-ethanol 
Method 1 
Borane in THF (22 ml, 1.0 M, 22.0 mmol) was added to (R)-alaninol (0.15 g, 195 mmol) 
in anhydrous THF under nitrogen atmosphere at 0 oC, forming the oxazaborolidine 
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catalyst in situ.  The reaction temperature was then raised to 30 oC and methyl-2-
benzyloxy-5-bromoacetylbenzoate (2.40 g, 6.6 mmol) added over a period of 30 min.  
The reaction mixture was stirred at 30 oC for a further 3 h, after which a further quantity 
of borane in THF (13 ml, 1.0 M, 13 mmol) was added.  After refluxing overnight, the 
reaction was quenched with 2N HCl (150 ml) and the mixture extracted with CH2Cl2. The 
extracts were washed with 2N NaOH and 10% aqueous NaCl solution and then dried with 
Na2SO4 before being concentrated to a solid which upon crystallization from 
CHCl3/hexane gave 1-(4-benzyloxy-3-hydroxymethyl-phenyl)-2-bromo-ethanol as a 
white powder (2.49 g, 93 %), nmax(CHCl3)/cm-1 3550 (s, free OH), and 3350 (br, OH); 
dH(CDCl3) 2.21 (1H, br s, OH), 2.58 (1H, br s, OH), 3.46 (1H, dd, J1 = 10.4, J2 = 8.9, 
CHaHbBr), 3.54 (1H, dd, J1 = 10.5, J2 = 3.5, CHaHbBr) 4.66 (2H, s, CH2OH), 4.81 (1H, 
dd, J1 = 8.8, J2 = 3.5, CH) 5.05 (2H, s, CH2Ph), 6.86 (1H, dd, J1 = 8.4, J2 = 5.6, Ar-H) and 
7.19-7.35 (7H, m, Ar-H); dC(CDCl3) 40.6 (CH2Br), 62.3 (CH2OH), 70.6 (CH2Ph), 73.8 
(CH), 112.1 (Ar), 126.7 (Ar), 126.9 (Ar), 127.7 (Ar), 128.6 (Ar), 129.1 (Ar), 130.2 
(quaternary–Ar), 133.2 (quaternary-Ar), 136.9 (quaternary-Ar) and 156.9 (quaternary-
Ar); [ ] °+= 4.2825Da  (c, 8.30 ´ 10-2 g/ml in CHCl3). 
 
Method 2: 
Borane in THF (22 ml, 1.0 M, 22.0 mmol) was added to (R,S)-ephedrine (0.32 g, 1.95 
mmol) in anhydrous THF (20 ml) under nitrogen atmosphere at 0 oC, forming the 
oxazaborolidine in situ.  The reaction temperature was raised to 30 oC whereupon methyl-
2 benzyloxy-5-bromoacetylbenzoate (2.38 g, 6.55 mmol) was added over a period of 30 
min.  The reaction mixture was stirred at 30 oC for a further 3h, after which an additional 
quantity of borane in THF (13 ml, 1.0 M, 13.0 mmol) was added. The reaction mixture 
was worked up as in method 1, affording the product (1.96 g, 88%); [ ] °+= 3.3525Da  (c, 
6.53 ´ 10-2 g/ml in CHCl3). 
 
Method 3 
Borane in THF (22 ml, 1.0 M, 22.0 mmol) was added to (+)-10-mercapto-iso-borneol 
(0.36, 1.95 mmol) in anhydrous THF (20 ml) under a nitrogen atmosphere at 0 oC, 
forming the oxazaborolidine catalyst in situ.  The reaction temperature was raised to 30 
oC and methyl 2-benzyloxy-5-bromoacetylbenzoate (2.42 g, 6.66 mmol) was added over a 
period of 30 min. The reaction was stirred at 30 oC for a further 3h, after which a further 
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quantity of borane in THF (13 ml, 1.0 M, 13 mmol) was added. The reaction mixture was 
worked up as in method 1, affording the product (2.08 g, 93%); [ ] °-= 7.4825Da  (c, 6.93  ´
10-2 g/ml in CHCl3). 
 
Method 4 
(-)-(1R,2R,4S)-1Methyl-4-(1-methyl-ethenyl)-2-(4-morpholinyl)cyclohexanol (0.43 g, 
1.95 mmol) was the amino alcohol and methyl 2-benzyloxy-5-bromoacetylbenzoate (2.36 
g, 6.50 mmol) were used in this method: (1.88 g, 84%); the procedure of the first three 
methods was followed:  The reaction mixture was worked up as in method 1, affording 
the product (1.88 g, 84%); [ ] °-= 8.16125Da  (c, 6.27 ´ 10-2 g/ml in CHCl3). 
 
3.3.18 2-t-Butylamino-1-(4-benzyloxy-3-hydroxymethylphenyl)ethanol 
2-Bromo-1-(4-benzyloxy-3-hydromethylphenyl)ethanol (1.7 g, 5.05 mmol) was dissolved 
in redistilled tert-butylamine and the solution refluxed for one week.  The reaction 
mixture was then concentrated under reduced pressure and the residue was taken up in 
CH2Cl2.  After being washed with 3N NaOH and water, the organic layer was dried over 
anhydrous Na2SO4 and concentrated to give 2-t-butylamino-1-(4-benzyloxy-3-
hydroxymethyl-phenyl)ethanol.  The crude product was recrystallised from benzene/ 
petroleum ether to give a white solid (1.21 g, 71 %), m p. 131.3-133.5 oC; nmax/cm-1 3600 
(s, free OH) and 3500 (br, OH and NH); dH(CDCl3) 1.33 (9H, s, C (CH3) 3), 2.26 (br s, 
OH and NH), 2.80 (1H, dd, J1 = 11.8, J2 = 9, CHaHb), 3.09 (1H, dd, J1 = 11.8, J2 = 3.5, 
CHaHb), 4.78 (1H, dd, J1 = 8.4, J2 = 3.5, CH), 4.95 (2H, s, CH2OH), 5.35 (2H, s, CH2Ph), 
7.14 (1H, d, J = 8.4, CH) and 7.46-7.69 (7H, m, Ar-H); dC(CDCl3) 29.6 (CH3) 50.7 
(CH2N), 62.4 (CH2OH), 70.5 (CH2Ph), 72.4 (CH), 111.9 (Ar), 126.6 (Ar), 126.7 (Ar), 
127.7 (Ar), 128.5 (Ar), 129.1 (Ar), 129.9 (quaternary-Ar), 135.8 (quaternary-Ar), 137.2 
(quaternary-Ar) and 156.3 (quaternary-Ar). 
 
3.3.19 2-t-Butylamino-1-(4-hydroxy-3-hydromethylphenyl)ethanol (Salbutamol) 
A solution of 2-t-butylamino-1-(4-benzyloxy-3-hydroxymethylphenyl)ethanol (0.15 g, 
0.43 mmol) in dry methanol (25 ml) along with 10% palladium on carbon (ca. 0.10 g) 
was treated with hydrogen gas at room temperature under 800 bar pressure for 4 h in a 
Parr pressure reactor.  When the reaction was complete the catalyst was removed by 
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filtration and the filtrate concentrated to give a solid which was recrystallized from 
ethanol/ethyl acetate: (76 mg, 76 %), dH (d6-acetone) 1.05 (9H, s, 3 x CH3) 2.51 (1H, dd, 
J1 = 11.3, J2 = 9.1, CHaHa’), 2.74 (1H, dd, J1 = 11.3, J3 = 3.7, CHbHb’) 4.50 (1H, dd, J2 = 
9.1, J3 = 3.7, CH) 6.79 (1H, d, J4 = 8.2, Ar-H) 7.10 (1H, dd, J4 = 8.2, J5 = 2.0, Ar-H) and 
7.3 (1H, d, J5 = 2.0, Ar-H). 
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4. APPENDIX 
 
 
Table A1. Conformational  analysis of salbutamol : Computed conformer distribution 
(MMFF94 gas phase). 
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1 0.00 7.68E-01 -53 2.16 3.10 -59 45.5118 -177 136.3614 
2 5.68 7.77E-02 -54 2.18 3.11 -60 4.6535 -178 13.8386 
3 5.73 7.63E-02 -53 2.16 3.11 -59 4.5221 -178 13.5403 
4 6.74 5.06E-02 -53 2.16 3.10 -59 2.9949 -177 8.9815 
5 10.82 9.78E-03 -54 2.18 3.12 -60 0.5854 -178 1.7412 
6 11.94 6.23E-03 -54 2.18 3.11 -60 0.3728 -178 1.1093 
7 14.97 1.83E-03 -53 2.15 3.10 -59 0.1083 -177 0.3247 
8 15.61 1.41E-03 48 3.13 2.33 44 0.0614 -73 0.1035 
9 15.66 1.39E-03 -53 2.17 3.11 -59 0.0824 -178 0.2461 
10 16.28 1.08E-03 -53 2.16 3.11 -59 0.0641 -178 0.1917 
11 16.75 8.94E-04 -53 2.16 3.10 -59 0.0530 -178 0.1587 
12 17.11 7.71E-04 -53 2.16 3.10 -59 0.0458 -178 0.1369 
13 17.29 7.19E-04 -54 2.18 3.12 -60 0.0430 -178 0.1280 
14 17.38 6.92E-04 47 2.71 2.40 44 0.0303 -73 0.0504 
15 18.80 3.90E-04 -175 4.44 4.00 177 0.0691 62 0.0243 
16 19.21 3.31E-04 -176 4.44 4.01 176 0.0581 61 0.0202 
17 19.36 3.12E-04 -53 2.17 3.11 -60 0.0186 -178 0.0555 
18 19.97 2.43E-04 -54 2.18 3.12 -60 0.0146 -178 0.0434 
19 21.57 1.28E-04 -171 3.94 4.02 -179 0.0228 67 0.0085 
20 21.97 1.09E-04 -50 3.81 2.30 -62 0.0067 -177 0.0193 
21 22.24 9.77E-05 -54 2.19 3.13 -60 0.0059 -179 0.0175 
22 22.26 9.66E-05 49 3.01 2.35 45 0.0043 -72 0.0069 
23 22.30 9.51E-05 47 3.51 2.33 42 0.0040 -75 0.0071 
24 23.38 6.17E-05 -52 2.12 3.06 -58 0.0036 -177 0.0109 
25 23.65 5.53E-05 47 2.66 2.41 43 0.0024 -73 0.0040 
26 23.81 5.17E-05 47 2.70 2.40 44 0.0023 -73 0.0038 
27 24.24 4.36E-05 -173 3.94 4.02 180 0.0078 65 0.0028 
28 24.77 3.51E-05 -50 3.82 2.31 -63 0.0022 -178 0.0063 
29 25.23 2.91E-05 52 3.08 2.36 48 0.0014 -69 0.0020 
30 25.79 2.33E-05 -175 4.45 4.01 177 0.0041 62 0.0014 
31 25.88 2.25E-05 -175 4.45 4.01 177 0.0040 62 0.0014 
32 26.01 2.13E-05 -48 3.14 2.25 -60 0.0013 -177 0.0038 
33 26.26 1.93E-05 -176 4.44 4.01 176 0.0034 61 0.0012 
34 27.11 1.37E-05 -64 3.92 3.13 -69 0.0009 173 0.0024 
35 27.12 1.36E-05 -171 3.94 4.02 -179 0.0024 66 0.0009 
36 27.52 1.16E-05 -53 2.57 2.70 -63 0.0007 -177 0.0021 
37 27.75 1.06E-05 55 3.01 2.36 50 0.0005 -67 0.0007 
38 28.26 8.58E-06 -171 3.94 4.02 -179 0.0015 67 0.0006 
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39 29.26 5.73E-06 -49 2.75 2.44 -59 0.0003 -174 0.0010 
40 29.80 4.63E-06 -173 3.94 4.02 180 0.0008 65 0.0003 
41 30.23 3.88E-06 -64 3.94 3.13 -70 0.0003 173 0.0007 
42 30.24 3.87E-06 53 3.09 2.37 49 0.0002 -68 0.0003 
43 30.55 3.41E-06 52 3.06 2.37 48 0.0002 -69 0.0002 
44 30.88 2.98E-06 -173 3.94 4.02 179 0.0005 64 0.0002 
45 31.18 2.64E-06 -53 2.17 3.11 -60 0.0002 -178 0.0005 
46 31.44 2.38E-06 -50 3.82 2.31 -62 0.0001 -178 0.0004 
47 31.45 2.38E-06 57 3.06 2.41 52 0.0001 -65 0.0002 
48 31.47 2.36E-06 48 2.71 2.41 44 0.0001 -72 0.0002 
49 31.70 2.14E-06 48 2.82 2.37 44 0.0001 -73 0.0002 
50 31.97 1.92E-06 49 2.94 2.36 45 0.0001 -72 0.0001 
51 32.17 1.77E-06 47 3.34 2.30 42 0.0001 -75 0.0001 
52 32.19 1.76E-06 47 2.76 2.39 43 0.0001 -73 0.0001 
53 32.82 1.37E-06 -53 2.16 3.11 -60 0.0001 -178 0.0002 
54 33.01 1.27E-06 58 2.98 2.41 53 0.0001 -63 0.0001 
55 33.31 1.12E-06 -50 3.85 2.46 -62 0.0001 -176 0.0002 
56 33.34 1.11E-06 -53 2.57 2.71 -63 0.0001 -177 0.0002 
57 33.52 1.03E-06 48 3.43 2.34 42 0.0000 -74 0.0001 
58 33.56 1.01E-06 48 3.01 2.34 44 0.0000 -73 0.0001 
59 33.79 9.23E-07 50 2.64 2.45 47 0.0000 -70 0.0001 
60 33.81 9.18E-07 47 2.90 2.35 43 0.0000 -74 0.0001 
61 33.85 9.00E-07 -53 2.58 2.70 -63 0.0001 -177 0.0002 
62 33.87 8.95E-07 55 3.01 2.37 50 0.0000 -66 0.0001 
63 34.22 7.76E-07 -64 3.92 3.13 -69 0.0001 174 0.0001 
64 34.28 7.58E-07 -64 3.92 3.15 -69 0.0001 173 0.0001 
65 34.44 7.12E-07 -176 4.44 4.01 176 0.0001 61 0.0000 
66 34.62 6.61E-07 -176 4.44 4.01 176 0.0001 61 0.0000 
67 34.64 6.56E-07 -176 4.44 4.01 176 0.0001 62 0.0000 
68 34.71 6.37E-07 -176 4.42 4.00 175 0.0001 61 0.0000 
69 34.75 6.26E-07 -174 4.44 4.01 178 0.0001 63 0.0000 
70 35.06 5.54E-07 47 2.61 2.43 44 0.0000 -73 0.0000 
71 35.09 5.47E-07 -50 3.86 2.47 -62 0.0000 -177 0.0001 
72 35.46 4.72E-07 -50 3.86 2.47 -62 0.0000 -177 0.0001 
73 35.98 3.81E-07 58 3.10 2.42 53 0.0000 -64 0.0000 
74 36.15 3.57E-07 -171 4.45 4.40 -176 0.0001 71 0.0000 
75 36.43 3.19E-07 -171 3.93 4.02 -178 0.0001 67 0.0000 
76 36.46 3.14E-07 56 3.05 2.41 51 0.0000 -66 0.0000 
77 36.53 3.06E-07 -176 4.44 4.00 176 0.0001 61 0.0000 
78 36.85 2.69E-07 -176 4.44 4.01 176 0.0000 61 0.0000 
79 36.92 2.61E-07 -173 3.94 4.02 180 0.0000 65 0.0000 
80 37.00 2.53E-07 -64 3.94 3.13 -70 0.0000 173 0.0000 
81 37.02 2.51E-07 -64 3.94 3.12 -70 0.0000 173 0.0000 
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82 37.73 1.88E-07 -54 2.55 2.73 -63 0.0000 -177 0.0000 
83 37.86 1.79E-07 51 3.44 2.36 45 0.0000 -72 0.0000 
84 37.94 1.73E-07 -172 3.95 4.02 -179 0.0000 66 0.0000 
85 38.18 1.57E-07 -54 2.56 2.72 -63 0.0000 -177 0.0000 
86 38.26 1.52E-07 -171 3.93 4.02 -178 0.0000 67 0.0000 
87 38.64 1.30E-07 -50 3.38 2.42 -62 0.0000 -177 0.0000 
88 39.07 1.10E-07 -172 3.94 4.02 -180 0.0000 65 0.0000 
89 39.52 9.14E-08 -50 3.80 2.31 -63 0.0000 -178 0.0000 
90 40.28 6.73E-08 -49 2.71 2.47 -60 0.0000 -174 0.0000 
91 40.60 5.92E-08 -48 3.16 2.25 -61 0.0000 -177 0.0000 
92 40.74 5.59E-08 56 3.09 2.39 51 0.0000 -66 0.0000 
93 40.78 5.50E-08 -91 4.18 4.19 -89 0.0000 156 0.0000 
94 40.94 5.16E-08 55 3.09 2.39 51 0.0000 -66 0.0000 
95 41.12 4.81E-08 175 4.42 4.42 167 0.0000 57 0.0000 
96 41.58 3.98E-08 -92 4.22 4.20 -91 0.0000 154 0.0000 
Sum  1.00     59.4  177.2 
 
 
Table A2. Conformational  analysis of salbutamol : conformer distribution from 
MMFF94 (aqueous) calculations. 
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1 0.00 7.96E-01 -53 2.16 3.10 -59 47.1694 -177 141.3279 
2 3.42 2.00E-01 -54 2.18 3.11 -60 11.9929 -178 35.6645 
3 16.89 8.75E-04 -171 3.94 4.02 -179 0.1562 67 0.0582 
4 18.53 4.52E-04 -173 3.94 4.02 180 0.0812 65 0.0293 
5 18.75 4.13E-04 52 3.08 2.36 48 0.0198 -69 0.0285 
6 19.20 3.44E-04 -175 4.44 4.00 177 0.0608 62 0.0214 
7 19.80 2.71E-04 -176 4.44 4.01 176 0.0476 61 0.0165 
8 20.72 1.87E-04 -53 2.57 2.70 -63 0.0118 -177 0.0331 
9 21.08 1.61E-04 -50 3.81 2.30 -62 0.0100 -177 0.0286 
10 21.21 1.53E-04 47 2.71 2.40 44 0.0067 -73 0.0111 
11 21.31 1.47E-04 -49 2.75 2.44 -59 0.0087 -174 0.0255 
12 21.33 1.46E-04 48 3.13 2.33 44 0.0064 -73 0.0107 
13 23.21 6.84E-05 -50 3.82 2.31 -63 0.0043 -178 0.0122 
14 23.41 6.31E-05 -64 3.92 3.13 -69 0.0044 173 0.0109 
15 23.52 6.04E-05 57 3.06 2.41 52 0.0031 -65 0.0039 
16 24.28 4.44E-05 55 3.01 2.36 50 0.0022 -67 0.0030 
17 25.59 2.61E-05 -48 3.14 2.25 -60 0.0016 -177 0.0046 
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18 25.64 2.56E-05 -64 3.94 3.13 -70 0.0018 173 0.0044 
19 25.95 2.26E-05 -53 2.16 3.11 -59 0.0013 -178 0.0040 
20 26.68 1.68E-05 -53 2.16 3.10 -59 0.0010 -177 0.0030 
21 33.35 1.14E-06 -171 4.45 4.40 -176 0.0002 71 0.0001 
22 37.99 1.76E-07 175 4.42 4.42 167 0.0000 57 0.0000 
23 41.10 5.02E-08 -91 4.18 4.19 -89 0.0000 156 0.0000 
24 42.32 3.06E-08 -92 4.22 4.20 -91 0.0000 154 0.0000 
25 43.05 2.28E-08 -53 2.15 3.10 -59 0.0000 -177 0.0000 
26 43.46 1.93E-08 -171 3.94 4.02 -179 0.0000 66 0.0000 
27 44.34 1.36E-08 -175 4.45 4.01 177 0.0000 62 0.0000 
28 44.34 1.35E-08 -171 3.94 4.02 -179 0.0000 67 0.0000 
29 44.65 1.20E-08 -175 4.45 4.01 177 0.0000 62 0.0000 
30 45.12 9.92E-09 -176 4.44 4.01 176 0.0000 61 0.0000 
31 45.49 8.55E-09 -54 2.19 3.13 -60 0.0000 -179 0.0000 
32 45.67 7.93E-09 -173 3.94 4.02 180 0.0000 65 0.0000 
33 45.88 7.30E-09 -173 3.94 4.02 179 0.0000 64 0.0000 
34 46.15 6.55E-09 -53 2.17 3.11 -59 0.0000 -178 0.0000 
35 46.48 5.72E-09 47 3.51 2.33 42 0.0000 -75 0.0000 
36 46.52 5.63E-09 -54 2.18 3.12 -60 0.0000 -178 0.0000 
37 46.87 4.89E-09 49 3.01 2.35 45 0.0000 -72 0.0000 
38 47.26 4.17E-09 -53 2.57 2.71 -63 0.0000 -177 0.0000 
39 47.33 4.06E-09 -53 2.58 2.70 -63 0.0000 -177 0.0000 
40 47.35 4.02E-09 -53 2.16 3.10 -59 0.0000 -178 0.0000 
41 47.46 3.85E-09 -53 2.16 3.11 -59 0.0000 -178 0.0000 
42 47.80 3.36E-09 -64 3.92 3.15 -69 0.0000 173 0.0000 
43 47.98 3.12E-09 -53 2.17 3.11 -60 0.0000 -178 0.0000 
44 48.05 3.04E-09 47 2.66 2.41 43 0.0000 -73 0.0000 
45 48.12 2.95E-09 -53 2.16 3.10 -59 0.0000 -178 0.0000 
46 48.27 2.79E-09 47 2.70 2.40 44 0.0000 -73 0.0000 
47 48.34 2.70E-09 -64 3.92 3.13 -69 0.0000 174 0.0000 
48 48.50 2.54E-09 -54 2.18 3.12 -60 0.0000 -178 0.0000 
49 49.23 1.89E-09 -50 3.82 2.31 -62 0.0000 -178 0.0000 
50 49.95 1.41E-09 -54 2.18 3.12 -60 0.0000 -178 0.0000 
51 50.84 9.84E-10 -54 2.18 3.11 -60 0.0000 -178 0.0000 
52 51.32 8.12E-10 -64 3.94 3.13 -70 0.0000 173 0.0000 
53 51.89 6.45E-10 -64 3.94 3.12 -70 0.0000 173 0.0000 
54 52.01 6.14E-10 -50 3.85 2.46 -62 0.0000 -176 0.0000 
55 52.38 5.30E-10 -52 2.12 3.06 -58 0.0000 -177 0.0000 
56 55.09 1.77E-10 -50 3.86 2.47 -62 0.0000 -177 0.0000 
57 55.10 1.77E-10 -50 3.86 2.47 -62 0.0000 -177 0.0000 
58 56.71 9.24E-11 -53 2.16 3.11 -60 0.0000 -178 0.0000 
59 58.34 4.78E-11 -50 3.38 2.42 -62 0.0000 -177 0.0000 
60 60.91 1.70E-11 -53 2.17 3.11 -60 0.0000 -178 0.0000 
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61 62.21 1.00E-11 -176 4.42 4.00 175 0.0000 61 0.0000 
62 62.90 7.62E-12 -173 3.94 4.02 180 0.0000 65 0.0000 
63 64.00 4.89E-12 -171 3.93 4.02 -178 0.0000 67 0.0000 
64 64.09 4.70E-12 -50 3.80 2.31 -63 0.0000 -178 0.0000 
65 64.34 4.26E-12 -172 3.94 4.02 -180 0.0000 65 0.0000 
66 64.36 4.22E-12 -172 3.95 4.02 -179 0.0000 66 0.0000 
67 64.80 3.53E-12 -171 3.93 4.02 -178 0.0000 67 0.0000 
68 64.95 3.33E-12 -176 4.44 4.01 176 0.0000 61 0.0000 
69 65.13 3.09E-12 -176 4.44 4.01 176 0.0000 61 0.0000 
70 65.21 2.99E-12 -176 4.44 4.00 176 0.0000 61 0.0000 
71 65.33 2.85E-12 -176 4.44 4.01 176 0.0000 62 0.0000 
72 65.56 2.60E-12 -174 4.44 4.01 178 0.0000 63 0.0000 
73 65.79 2.37E-12 -176 4.44 4.01 176 0.0000 61 0.0000 
74 66.24 1.98E-12 47 3.34 2.30 42 0.0000 -75 0.0000 
75 66.87 1.53E-12 48 2.71 2.41 44 0.0000 -72 0.0000 
76 67.40 1.24E-12 48 2.82 2.37 44 0.0000 -73 0.0000 
77 67.60 1.14E-12 47 2.76 2.39 43 0.0000 -73 0.0000 
78 67.89 1.02E-12 -48 3.16 2.25 -61 0.0000 -177 0.0000 
79 68.04 9.55E-13 52 3.06 2.37 48 0.0000 -69 0.0000 
80 68.20 8.96E-13 49 2.94 2.36 45 0.0000 -72 0.0000 
81 68.33 8.49E-13 48 3.43 2.34 42 0.0000 -74 0.0000 
82 68.55 7.79E-13 53 3.09 2.37 49 0.0000 -68 0.0000 
83 68.71 7.31E-13 55 3.09 2.39 51 0.0000 -66 0.0000 
84 69.22 5.94E-13 47 2.90 2.35 43 0.0000 -74 0.0000 
85 69.41 5.50E-13 56 3.09 2.39 51 0.0000 -66 0.0000 
86 69.65 4.99E-13 48 3.01 2.34 44 0.0000 -73 0.0000 
87 69.80 4.71E-13 51 3.44 2.36 45 0.0000 -72 0.0000 
88 70.69 3.28E-13 -54 2.55 2.73 -63 0.0000 -177 0.0000 
89 70.91 3.00E-13 -54 2.56 2.72 -63 0.0000 -177 0.0000 
90 71.79 2.10E-13 47 2.61 2.43 44 0.0000 -73 0.0000 
91 72.30 1.71E-13 -49 2.71 2.47 -60 0.0000 -174 0.0000 
92 72.37 1.67E-13 56 3.05 2.41 51 0.0000 -66 0.0000 
93 72.70 1.46E-13 50 2.64 2.45 47 0.0000 -70 0.0000 
94 73.07 1.26E-13 55 3.01 2.37 50 0.0000 -66 0.0000 
95 73.51 1.05E-13 58 3.10 2.42 53 0.0000 -64 0.0000 
96 73.66 9.88E-14 58 2.98 2.41 53 0.0000 -63 0.0000 
Sum  1.00     59.6  177.3 
 
 
 
